<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="hnpcc" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">hnpcc</book-part-id>
      <title-group>
        <title>Lynch Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: HNPCC, Hereditary Non-Polyposis Colon Cancer</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kohlmann</surname>
            <given-names>Wendy</given-names>
          </name>
          <degrees>MS</degrees>
          <email>wendy.kohlmann@hci.utah.edu</email>
          <aff>University of Utah Huntsman Cancer Institute<break/>Salt Lake City, Utah</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gruber</surname>
            <given-names>Stephen B</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <email>sgruber@usc.edu</email>
          <aff>USC Norris Comprehensive Cancer Center<break/>Los Angeles, California</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2004-02-05" date-type="created">
          <day>5</day>
          <month>2</month>
          <year>2004</year>
        </date>
        <date iso-8601-date="2014-05-22" date-type="updated">
          <day>22</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date iso-8601-date="2012-09-20" date-type="revised">
          <day>20</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="x-lpd" document-type="chapter">Lymphoproliferative Disease, X-Linked</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="lpi" document-type="chapter">Lysinuric Protein Intolerance</related-object>
      <abstract id="hnpcc.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Lynch syndrome, caused by a germline pathogenic variant in a mismatch repair gene and associated with tumors exhibiting microsatellite instability (MSI), is characterized by an increased risk for colon cancer and cancers of the endometrium, ovary, stomach, small intestine, hepatobiliary tract, urinary tract, brain, and skin. In individuals with Lynch syndrome the following life time risks for cancer are seen: 52%-82% for colorectal cancer (mean age at diagnosis 44-61 years); 25%-60% for endometrial cancer in women (mean age at diagnosis 48-62 years); 6% to 13% for gastric cancer (mean age at diagnosis 56 years); and 4%-12% for ovarian cancer (mean age at diagnosis 42.5 years; approximately 30% are diagnosed before age 40 years). The risk for other Lynch syndrome-related cancers is lower, though substantially increased over general population rates.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of Lynch syndrome can be made on the basis of family history in those families meeting the Amsterdam criteria who have tumor microsatellite instability (MSI) or on the basis of molecular genetic testing in an individual or family with a germline pathogenic variant in one of four mismatch repair (MMR) genes <italic toggle="yes">(MLH1, MSH2, MSH6,</italic> and <italic toggle="yes">PMS2)</italic>. <italic toggle="yes">MLH1</italic> and <italic toggle="yes">MSH2</italic> germline pathogenic variants account for approximately 90% of pathogenic variants in families with Lynch syndrome; <italic toggle="yes">MSH6</italic> pathogenic variants in about 7%-10%; and <italic toggle="yes">PMS2</italic> pathogenic variants in fewer than 5%. Germline deletions in <italic toggle="yes">EPCAM</italic> (not a mismatch repair gene) inactivate <italic toggle="yes">MSH2</italic> in about 1% of individuals with Lynch syndrome.</p>
          <p>Genetic testing for Lynch syndrome is ideally performed in a stepwise manner:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Tumor testing</p>
              <list list-type="alpha-lower">
                <list-item>
                  <label>a</label>
                  <p>Evaluation of tumor tissue for MSI through molecular MSI testing and/or immunohistochemistry (IHC) of the four MMR proteins. The presence of MSI in the tumor alone is not sufficient to diagnosis Lynch syndrome because 10%-15% of sporadic colorectal cancers exhibit MSI. IHC testing helps identify the MMR gene that most likely harbors a germline pathogenic variant.</p>
                </list-item>
                <list-item>
                  <label>b</label>
                  <p>Molecular genetic testing of the tumor for <italic toggle="yes">MLH1</italic> methylation and somatic <italic toggle="yes">BRAF</italic> pathogenic variant to help identify those tumors more likely to be sporadic than hereditary.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <label>2</label>
              <p>Molecular genetic testing of the MMR genes to identify a germline pathogenic variant when findings are consistent with Lynch syndrome.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> For colon cancer, full colectomy with ileorectal anastomosis is recommended.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Prophylactic removal of the colon prior to the development of colon cancer is generally not recommended for individuals known to have Lynch syndrome because routine colonoscopy is an effective preventive measure. Prophylactic removal of the uterus and ovaries (prior to the development of cancer) can be considered after childbearing is completed.</p>
          <p><italic toggle="yes">Surveillance:</italic> Colonoscopy with removal of precancerous polyps every one to two years beginning between ages 20 and 25 years or two to five years before the earliest age of diagnosis in the family, whichever is earlier. The efficacy of surveillance for cancer of the endometrium, ovary, stomach, duodenum, and urinary tract is unknown.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Cigarette smoking.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Genetic testing for Lynch syndrome is generally not recommended for at-risk individuals younger than age 18 years; however, because it is recommended that screening begin ten years before the earliest age of cancer onset in a family, molecular genetic testing and screening colonoscopy may need to begin before age 18 years in some families.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Lynch syndrome is inherited in an autosomal dominant manner. The majority of individuals diagnosed with Lynch syndrome have inherited the condition from a parent. However, because of incomplete penetrance, variable age of cancer development, cancer risk reduction as a result of screening or prophylactic surgery, or early death, not all individuals with a pathogenic variant in one of the genes associated with Lynch syndrome have a parent who had cancer. Each child of an individual with Lynch syndrome has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in the family is known. Requests for prenatal testing for typically adult-onset conditions which (like Lynch syndrome) have treatment available are not common.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="hnpcc.Diagnosis">
        <title>Diagnosis</title>
        <p>The diagnosis of Lynch syndrome can be made on the basis of family history in those families meeting the Amsterdam criteria who have tumor microsatellite instability (MSI) or on the basis molecular genetic testing in an individual or family with a germline pathogenic variant in one of four mismatch repair (MMR) genes <italic toggle="yes">(MLH1, MSH2, MSH6,</italic> and <italic toggle="yes">PMS2)</italic> or in <italic toggle="yes">EPCAM</italic>.</p>
        <p>In 1990 the International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer established the first clinical criteria, the Amsterdam criteria, to define hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) for the purpose of identifying families for research studies. These criteria were later modified (Amsterdam II Criteria) to include the other Lynch syndrome-related cancers (<xref ref-type="table" rid="hnpcc.T.amsterdam_and_amsterdam_ii_crite">Table 1</xref>).</p>
        <table-wrap id="hnpcc.T.amsterdam_and_amsterdam_ii_crite" position="anchor" orientation="portrait">
          <label>Table 1. </label>
          <caption>
            <p>Amsterdam and Amsterdam II Criteria for the Clinical Diagnosis of HNPCC</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_hnpcc.T.amsterdam_and_amsterdam_ii_crite_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Amsterdam Criteria&#x000a0;<sup>1</sup></th>
                <th id="hd_h_hnpcc.T.amsterdam_and_amsterdam_ii_crite_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Amsterdam II Criteria&#x000a0;<sup>2</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_hnpcc.T.amsterdam_and_amsterdam_ii_crite_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p><bold>Three</bold> or more family members, one of whom is a first-degree&#x000a0;<sup>3</sup> relative of the other two, with a confirmed diagnosis of colorectal cancer</p>
                    </list-item>
                    <list-item>
                      <p><bold>Two</bold> successive affected generations</p>
                    </list-item>
                    <list-item>
                      <p><bold>One</bold> or more colon cancers diagnosed before age 50 years</p>
                    </list-item>
                    <list-item>
                      <p>Exclusion of <related-object link-type="booklink" source-id="gene" document-id="fap" document-type="chapter">familial adenomatous polyposis</related-object> (FAP)</p>
                    </list-item>
                  </list>
                </td>
                <td headers="hd_h_hnpcc.T.amsterdam_and_amsterdam_ii_crite_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p><bold>Three</bold> or more family members (one of whom is a first-degree relative&#x000a0;<sup>3</sup> of the other two) with HNPCC-related cancers&#x000a0;<sup>4</sup></p>
                    </list-item>
                    <list-item>
                      <p><bold>Two</bold> successive affected generations</p>
                    </list-item>
                    <list-item>
                      <p><bold>One</bold> or more of the HNPCC-related cancers diagnosed before age 50 years</p>
                    </list-item>
                    <list-item>
                      <p>Exclusion of <related-object link-type="booklink" source-id="gene" document-id="fap" document-type="chapter">familial adenomatous polyposis</related-object> (FAP)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="hnpcc.TF.1.1">
              <label>1. </label>
              <p>
                <xref ref-type="bibr" rid="hnpcc.REF.vasen.1991.424">Vasen et al [1991]</xref>
              </p>
            </fn>
            <fn id="hnpcc.TF.1.2">
              <label>2. </label>
              <p>
                <xref ref-type="bibr" rid="hnpcc.REF.vasen.1999.1453">Vasen et al [1999]</xref>
              </p>
            </fn>
            <fn id="hnpcc.TF.1.3">
              <label>3. </label>
              <p>Parent, child, or sibling</p>
            </fn>
            <fn id="hnpcc.TF.1.4">
              <label>4. </label>
              <p>Colorectal, endometrial, stomach, small intestinal, hepatobiliary, renal pelvic, or ureteral</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Although the Amsterdam criteria can be a significant predictor of a germline pathogenic variant in an MMR gene in families that fulfill the criteria, the Amsterdam criteria nonetheless fail to identify a large portion of persons with a germline MMR gene pathogenic variant. Therefore, family history and the Amsterdam criteria cannot be relied on to identify all individuals with a germline pathogenic variant in one of the MMR genes.</p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="bibr" rid="hnpcc.REF.sjursen.2010.579">Sjursen et al [2010]</xref> found the sensitivity of the Amsterdam II criteria to be 87%, 62%, 38%, and 48% for identifying persons with a <italic toggle="yes">MLH1</italic>, <italic toggle="yes">MSH2,</italic>
<italic toggle="yes">PMS2,</italic> or <italic toggle="yes">MSH6</italic> germline pathogenic variant, respectively.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="hnpcc.REF.hampel.2005.415">Hampel et al [2005]</xref> also reported that in a population-based study of persons with colon cancer, only three of 23 persons with a germline pathogenic variant in an MMR gene met the Amsterdam criteria.</p>
          </list-item>
        </list>
        <p>Note: An individual found to have a deleterious germline variant in one of the four MMR genes associated with Lynch syndrome is considered to have Lynch syndrome regardless of the extent of the family history.</p>
        <sec id="hnpcc.Testing">
          <title>Testing</title>
          <sec id="hnpcc.Tumor_Testing">
            <title>Tumor Testing</title>
            <p><bold>Microsatellite instability (MSI) and/or immunohistochemistry (IHC) tests</bold> can be performed on tumor tissue in order to:</p>
            <list list-type="bullet">
              <list-item>
                <p>Establish the probability of Lynch syndrome; and</p>
              </list-item>
              <list-item>
                <p>Identify which gene is most likely to have a causative germline variant in a person with Lynch syndrome.</p>
              </list-item>
            </list>
            <p>Plausible etiologies to explain the results of tumor testing and recommended additional testing based on the results of tumor testing are summarized in <xref ref-type="table" rid="hnpcc.T.summary_of_tumor_tissue_test_res">Table 2</xref>.</p>
            <p>
              <bold>Tissue type</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Although testing of tissue from colorectal carcinoma is clearly preferable, testing can be considered on an adenomatous polyp if cancer tissue is not available. However, abnormal MSI or IHC may be less reliably identified in Lynch syndrome-related polyps. Evaluation of 109 polyps from 69 individuals with a pathogenic variant found that only 79% of the adenomas demonstrated loss of MMR expression. Polyps with high-grade dysplasia are more likely to be concordant with pathogenic variant status than polyps with low-grade dysplasia [<xref ref-type="bibr" rid="hnpcc.REF.walsh.2012.722">Walsh et al 2012</xref>].</p>
              </list-item>
              <list-item>
                <p>Testing can also be used to screen endometrial cancers for defective MMR [<xref ref-type="bibr" rid="hnpcc.REF.backes.2009.486">Backes et al 2009</xref>].</p>
              </list-item>
            </list>
            <p><bold>Immunohistochemistry (IHC) of tumor tissue.</bold> IHC detects the presence or absence of the protein products expressed by mismatch repair genes. The MMR gene products function as dimers: MSH2 protein may complex with MSH6 or MSH3 protein, and MLH1 protein complexes with PMS2 or PMS1 protein. MSH6 and PMS2 proteins are unstable when not paired in a complex; thus, a germline pathogenic variant in <italic toggle="yes">MSH2</italic> typically results in loss of expression of the proteins MSH2/MSH6 and a germline pathogenic variant in <italic toggle="yes">MLH1</italic> results in loss of expression of the proteins MLH1/PMS2. However, germline pathogenic variants in <italic toggle="yes">MSH6</italic> and <italic toggle="yes">PMS2</italic> typically do not result in loss of MSH2 or MLH1 expression because these proteins are still present in other pairings [<xref ref-type="bibr" rid="hnpcc.REF.bellizzi.2009.405">Bellizzi &#x00026; Frankel 2009</xref>].</p>
            <p>Advantages of IHC testing:</p>
            <list list-type="bullet">
              <list-item>
                <p>IHC testing is effective for detecting tumors resulting from MMR deficiency. Antibodies for MSH2, MLH1, MSH6, and PMS2 have demonstrated 92% sensitivity for identifying tumors that arise in individuals with a germline pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.shia.2008.293">Shia 2008</xref>].</p>
              </list-item>
              <list-item>
                <p>IHC testing is readily available at most centers and is technically easy to perform.</p>
              </list-item>
              <list-item>
                <p>IHC testing identifies in most individuals the MMR gene in which either a germline pathogenic variant or a somatic alteration that silences gene expression is most likely to be found [<xref ref-type="bibr" rid="hnpcc.REF.de_leeuw.2000.328">de Leeuw et al 2000</xref>, <xref ref-type="bibr" rid="hnpcc.REF.cunningham.2001.780">Cunningham et al 2001</xref>], thus significantly reducing the cost of molecular genetic testing.</p>
              </list-item>
            </list>
            <p>Limitations of IHC testing:</p>
            <list list-type="bullet">
              <list-item>
                <p>Variation in tissue fixation and other technical issues can result in weak or equivocal staining patterns [<xref ref-type="bibr" rid="hnpcc.REF.shia.2008.293">Shia 2008</xref>].</p>
              </list-item>
              <list-item>
                <p>It is possible that some missense germline variants will not result in the absence of a detectable protein product [<xref ref-type="bibr" rid="hnpcc.REF.wahlberg.2002.3485">Wahlberg et al 2002</xref>, <xref ref-type="bibr" rid="hnpcc.REF.bellizzi.2009.405">Bellizzi &#x00026; Frankel 2009</xref>].</p>
              </list-item>
              <list-item>
                <p>It may be less reliable when performed on small tissue samples [<xref ref-type="bibr" rid="hnpcc.REF.zhang.2008.301">Zhang 2008</xref>].</p>
              </list-item>
            </list>
            <p><bold>Microsatellite instability (MSI) testing of tumor tissue.</bold> Genes in the mismatch repair (MMR) pathway are responsible for identifying and repairing single nucleotide mismatches and insertion or deletion loops that occur as cells grow and divide [<xref ref-type="bibr" rid="hnpcc.REF.gruber.2003.137">Gruber &#x00026; Kohlmann 2003</xref>]. Defects in the genes involved with mismatch repair lead to an accumulation of somatic pathogenic variants in a cell, which may result in the cell becoming malignant.</p>
            <p>Microsatellites are stretches of DNA with a repetitive sequence of nucleotides (e.g., AAAAA or CGCGCGCG) that are particularly susceptible to acquiring errors when the mismatch repair gene function is impaired. Cancers arising in cells with defective mismatch repair gene function exhibit an inconsistent number of microsatellite nucleotide repeats when compared to normal tissue, a finding referred to as "microsatellite instability." See <xref ref-type="fig" rid="hnpcc.F1">Figure 1</xref>.</p>
            <p>MSI, assessed using a panel of microsatellite markers, is compared in tumor tissue and normal tissue. A 1997 NCI consensus meeting recommended testing a core panel of five markers: BAT25, BAT26, D2S123, D5S346, and D17S250 [<xref ref-type="bibr" rid="hnpcc.REF.boland.1998.5248">Boland et al 1998</xref>]. This panel remains the most commonly used, and it includes two mononucleotide and three dinucleotide repeats. However, many labs are now using a variety of panels [<xref ref-type="bibr" rid="hnpcc.REF.hegde.2014.101">Hegde et al 2014</xref>]. A tumor continues to be classified as follows [<xref ref-type="bibr" rid="hnpcc.REF.boland.1998.5248">Boland et al 1998</xref>, <xref ref-type="bibr" rid="hnpcc.REF.hegde.2014.101">Hegde et al 2014</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>MSI-high</bold> if two or more of the five markers of the core panel show instability or more than 30% of markers show instability in other marker panels.</p>
              </list-item>
              <list-item>
                <p><bold>MSI-low</bold> if one of the five markers in the core panel shows instability or fewer than 30% of markers show instability in other marker panels.</p>
              </list-item>
              <list-item>
                <p><bold>MSI-stable</bold> if 0 (or 0%) of the markers show instability in the core panel or other marker panels.</p>
              </list-item>
            </list>
            <p>Note: Although some clinical laboratories use additional markers when performing MSI testing, there is a lack of consensus on the markers beyond the five designed by <xref ref-type="bibr" rid="hnpcc.REF.boland.1998.5248">Boland et al [1998]</xref>.</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Colon tumors.</bold> When adequate tissue is available, studies of Lynch syndrome-associated adenomas suggest a slightly lower rate of MSI compared to invasive cancers, with approximately 80% of adenomas being MSI-high (see <xref ref-type="table" rid="hnpcc.T.summary_of_germline_molecular_ge">Table 3</xref>). Adenomas with high-grade dysplasia are more likely to exhibit MSI than early polyps [<xref ref-type="bibr" rid="hnpcc.REF.iino.2000.37">Iino et al 2000</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Endometrial cancers.</bold> Approximately 20%-30% of endometrial cancers exhibit MSI, and as with colon cancers the majority are the result of somatic <italic toggle="yes">MLH1</italic> promoter methylation [<xref ref-type="bibr" rid="hnpcc.REF.hampel.2006.7810">Hampel et al 2006</xref>].</p>
              </list-item>
            </list>
            <p>Advantages of MSI testing:</p>
            <list list-type="bullet">
              <list-item>
                <p>MSI testing is an effective method for determining which tumors arise from MMR deficiency. Studies have demonstrated that the sensitivity of MSI testing for identifying tumors that arise in individuals with a germline MMR gene variant is 93% [<xref ref-type="bibr" rid="hnpcc.REF.shia.2008.293">Shia 2008</xref>].</p>
              </list-item>
              <list-item>
                <p>MSI testing may be positive (i.e., MSI-high, identifying a tumor as arising from MMR deficiency) when the IHC studies have given a false negative result (e.g., because the appropriate antibody was not included in the test; the protein is present, but nonfunctional) [<xref ref-type="bibr" rid="hnpcc.REF.shia.2008.293">Shia 2008</xref>].</p>
              </list-item>
              <list-item>
                <p>MSI testing requires very little tissue [<xref ref-type="bibr" rid="hnpcc.REF.zhang.2008.301">Zhang 2008</xref>].</p>
              </list-item>
              <list-item>
                <p>MSI testing is highly reproducible [<xref ref-type="bibr" rid="hnpcc.REF.zhang.2008.301">Zhang 2008</xref>].</p>
              </list-item>
            </list>
            <p>Limitations of MSI testing:</p>
            <list list-type="bullet">
              <list-item>
                <p>It may not be readily available at all centers because it requires microdissection and molecular analysis [<xref ref-type="bibr" rid="hnpcc.REF.bellizzi.2009.405">Bellizzi &#x00026; Frankel 2009</xref>].</p>
              </list-item>
              <list-item>
                <p>In some tumors MSI cannot be detected because of technical challenges such as lack of DNA in extremely mucinous tumors [<xref ref-type="bibr" rid="hnpcc.REF.hampel.2005.415">Hampel et al 2005</xref>].</p>
              </list-item>
              <list-item>
                <p>A small portion of Lynch syndrome-related tumors will not show evidence of MMR deficiency [<xref ref-type="bibr" rid="hnpcc.REF.shia.2008.293">Shia 2008</xref>].</p>
              </list-item>
              <list-item>
                <p>It does not reduce the cost of molecular testing because it does not help identify the gene that is most likely mutated.</p>
              </list-item>
            </list>
            <p>
              <bold><italic toggle="yes">BRAF</italic> testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Colon tumors</bold>. <italic toggle="yes">BRAF</italic> pathogenic variants, the most common being <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004333.4">NM_004333.4</ext-link>:c.1799T&#x0003e;A (p.Val600Glu, or V600E), occur in 15% of colorectal cancers. <italic toggle="yes">BRAF</italic> pathogenic variants are thought to be rare in Lynch syndrome-related cancers and, thus, in general the presence of a <italic toggle="yes">BRAF</italic> pathogenic variant rules out the diagnosis of Lynch syndrome [<xref ref-type="bibr" rid="hnpcc.REF.bellizzi.2009.405">Bellizzi &#x00026; Frankel 2009</xref>, <xref ref-type="bibr" rid="hnpcc.REF.bouzourene.2010.167">Bouzourene et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Endometrial cancers</bold>. <italic toggle="yes">BRAF</italic> pathogenic variants are not common in sporadic endometrial cancers; thus, <italic toggle="yes">BRAF</italic> testing is not helpful in distinguishing endometrial cancers that are sporadic from those that are Lynch syndrome-related [<xref ref-type="bibr" rid="hnpcc.REF.kawaguchi.2009.1541">Kawaguchi et al 2009</xref>].</p>
              </list-item>
            </list>
            <p><bold>Methylation analysis of tumor tissue.</bold> The majority of MSI is caused by somatic methylation of the promoter region of <italic toggle="yes">MLH1</italic> that silences gene expression in the tumor tissue; thus, the finding of <italic toggle="yes">MLH1</italic> promoter methylation can often help eliminate the diagnosis of Lynch syndrome.</p>
            <p>However, inactivation of the remaining functional allele by methylation can also be the &#x0201c;second hit&#x0201d; that causes homozygous inactivation of the gene, resulting in tumor development in an individual with a germline <italic toggle="yes">MLH1</italic> pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.bellizzi.2009.405">Bellizzi &#x00026; Frankel 2009</xref>, <xref ref-type="bibr" rid="hnpcc.REF.niessen.2009.737">Niessen et al 2009</xref>]. Therefore, the diagnosis of Lynch syndrome cannot be eliminated by the presence of <italic toggle="yes">MLH1</italic> promoter hypermethylation in an individual with early-onset colon cancer, strong family history, or other risk factors.</p>
            <p>Somatic methylation of the functional <italic toggle="yes">MSH2</italic> allele has been found to be the second hit in approximately 24% of <italic toggle="yes">MSH2-</italic>related cancers. However, methylation of <italic toggle="yes">MSH2</italic> has not been found to be a cause of sporadic colorectal cancers [<xref ref-type="bibr" rid="hnpcc.REF.nagasaka.2010.3098">Nagasaka et al 2010</xref>].</p>
            <table-wrap id="hnpcc.T.summary_of_tumor_tissue_test_res" position="anchor" orientation="portrait">
              <label>Table 2. </label>
              <caption>
                <p>Summary of Tumor Tissue Test Results, Interpretation, and Additional Testing</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1" valign="middle" colspan="7" align="left" scope="colgroup" rowspan="1">Tumor Testing&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2">Plausible Etiologies</th>
                    <th id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3">Additional Testing&#x000a0;<sup>2</sup></th>
                  </tr>
                  <tr>
                    <th headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1" id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1" valign="middle" colspan="4" align="left" scope="colgroup" rowspan="1">Immunohistochemistry (IHC)</th>
                    <th headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1">MSI</th>
                    <th headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1"><italic toggle="yes">BRAF</italic> V600E&#x000a0;<sup>3</sup></th>
                    <th headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1"><italic toggle="yes">MLH1</italic> Promoter Methylation</th>
                  </tr>
                  <tr>
                    <th headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1" id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                      <italic toggle="yes">MLH1</italic>
                    </th>
                    <th headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1" id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                      <italic toggle="yes">MSH2</italic>
                    </th>
                    <th headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1" id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                      <italic toggle="yes">MSH6</italic>
                    </th>
                    <th headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1" id="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">
                      <italic toggle="yes">PMS2</italic>
                    </th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">MSS/ MSI-Low</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sporadic cancer</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">MSI-High</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Germline mutaion of any one of the known MMR genes</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Consider germline testing of <italic toggle="yes">MLH1</italic> and <italic toggle="yes">MSH2</italic> followed by <italic toggle="yes">MSH6</italic> and possibly <italic toggle="yes">PMS2.</italic></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">MSI-High</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sporadic cancer or germline mutation of any one of the known MMR genes</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Consider IHC testing to guide germline testing.<break/>If IHC not done, <italic toggle="yes">MLH1</italic> and <italic toggle="yes">MSH2</italic> germline testing followed by <italic toggle="yes">MSH6</italic> and possibly <italic toggle="yes">PMS2</italic></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sporadic cancer<break/>Germline <italic toggle="yes">MLH1</italic> mutation</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Consider <italic toggle="yes">BRAF</italic>&#x000a0;<sup>3</sup>/ methylation studies;<break/><italic toggle="yes">MLH1</italic> germline testing if no pathogenic variant detected in <italic toggle="yes">BRAF</italic> and/or hypermethylation, or testing not done</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Pos</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sporadic cancer</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Neg</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">Pos</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sporadic cancer<break/>Rarely, <italic toggle="yes">MLH1</italic> germline mutation or constitutional <italic toggle="yes">MLH1</italic> epimutation</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None, unless young onset or significant family history then consider <italic toggle="yes">MLH1</italic> germline testing or if young onset consider evaluation for constitutional <italic toggle="yes">MLH1</italic> epimutation</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Neg</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">Neg</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Germline <italic toggle="yes">MLH1</italic> mutation</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MLH1</italic> germline testing</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Germline <italic toggle="yes">MSH2</italic> mutation<break/>Germline <italic toggle="yes">EPCAM</italic> mutation<break/>Rarely, germline <italic toggle="yes">MSH6</italic> mutation</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MSH2</italic> germline testing<break/>If no pathogenic variant detected consider <italic toggle="yes">EPCAM</italic> testing (if not already done).<break/>If no pathogenic variant detected in <italic toggle="yes">MSH2</italic> or <italic toggle="yes">EPCAM</italic> (if not included with the original large deletion testing), consider <italic toggle="yes">MSH6</italic> germline testing.</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Germline <italic toggle="yes">MLH1</italic> mutation</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MLH1</italic> germline testing</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Germline <italic toggle="yes">PMS2</italic> mutation<break/>Germline <italic toggle="yes">MLH1</italic> mutation</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">PMS2</italic> germline testing<break/>If no pathogenic variant detected in <italic toggle="yes">PMS2</italic>, <italic toggle="yes">MLH1</italic> germline testing</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Germline <italic toggle="yes">MSH2</italic> mutation</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MSH2</italic> germline testing</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_3" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_3_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_1 hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Germline <italic toggle="yes">MSH6</italic> mutation<break/>Germline <italic toggle="yes">MSH2</italic> mutation</td>
                    <td headers="hd_h_hnpcc.T.summary_of_tumor_tissue_test_res_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MSH6</italic> germline testing<break/>If no pathogenic variant detected in <italic toggle="yes">MSH6,</italic> consider <italic toggle="yes">MSH2</italic> germline testing.</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p><xref ref-type="bibr" rid="hnpcc.REF9">NCCN [2013]</xref> (click <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#colorectal_screening">here</ext-link> for full text; registration required)</p>
                </fn>
                <fn>
                  <p>Empty cells indicate either that testing was not done or that results may not influence testing strategy.</p>
                </fn>
                <fn>
                  <p>MSI = microsatellite instability</p>
                </fn>
                <fn>
                  <p>MSS = MSI-stable</p>
                </fn>
                <fn id="hnpcc.TF.2.1">
                  <label>+&#x000a0;</label>
                  <p>= normal staining of protein</p>
                </fn>
                <fn>
                  <p>&#x02013;&#x000a0;= absent staining of protein</p>
                </fn>
                <fn>
                  <p>Neg = negative</p>
                </fn>
                <fn>
                  <p>Pos = positive</p>
                </fn>
                <fn id="hnpcc.TF.2.2">
                  <label>1. </label>
                  <p>Tumor testing strategies apply to colorectal and endometrial cancers. Limited data exist regarding the efficacy of tumor testing in other Lynch syndrome tumors.</p>
                </fn>
                <fn id="hnpcc.TF.2.3">
                  <label>2. </label>
                  <p>For information on testing for germline pathogenic variants, see <xref ref-type="sec" rid="hnpcc.Molecular_Genetic_Testing">Molecular Genetic Testing</xref> and <xref ref-type="table" rid="hnpcc.T.summary_of_germline_molecular_ge">Table 3</xref>.</p>
                </fn>
                <fn id="hnpcc.TF.2.4">
                  <label>3. </label>
                  <p>Testing is not appropriate for tumors other than colorectal cancer.</p>
                </fn>
                <fn id="hnpcc.TF.2.5">
                  <label>4. </label>
                  <p>In the presence of strong family history (i.e., Amsterdam criteria are met), additional testing may be warranted in the proband or tumor testing in another affected family member considered because of the possibility that the original tumor selected for testing was a sporadic colorectal cancer.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="hnpcc.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> Five genes (<italic toggle="yes">MLH1,</italic>
<italic toggle="yes">MSH2,</italic>
<italic toggle="yes">MSH6, PMS2, and EPCAM</italic> [formerly known as <italic toggle="yes">TACSTD1</italic>]) in which germline pathogenic variants disrupt the mismatch repair (MMR) pathway and cause Lynch syndrome have been identified (see <xref ref-type="table" rid="hnpcc.T.summary_of_germline_molecular_ge">Table 3</xref>).</p>
            <p>Note: Although <italic toggle="yes">EPCAM</italic> is not an MMR gene, recurrent germline deletions of the 3' region result in silencing of the adjacent downstream <italic toggle="yes">MSH2</italic> by hypermethylation [<xref ref-type="bibr" rid="hnpcc.REF.niessen.2009.737">Niessen et al 2009</xref>, <xref ref-type="bibr" rid="hnpcc.REF.goel.2011.869">Goel et al 2011</xref>, <xref ref-type="bibr" rid="hnpcc.REF.kuiper.2011.407">Kuiper et al 2011</xref>].</p>
            <p><bold>Evidence for additional locus heterogeneity.</bold> There are a few case reports of germline <italic toggle="yes">MLH3</italic>, <italic toggle="yes">MSH3</italic>, <italic toggle="yes">EXO1</italic>, <italic toggle="yes">PMS1</italic>, or <italic toggle="yes">TGFBR2</italic> variants in some families with Lynch syndrome; however, the clinical significance, if any, of allelic variants in these genes in Lynch syndrome has not yet been determined [<xref ref-type="bibr" rid="hnpcc.REF.lu.1998.17">Lu et al 1998</xref>, <xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2003.1174">Peltom&#x000e4;ki 2003</xref>]. While these and other genes may play a role in the mismatch repair process, there continues to be no confirmed role for mutation testing of these genes as part of a Lynch syndrome evaluation [<xref ref-type="bibr" rid="hnpcc.REF.thompson.2004.215">Thompson et al 2004</xref>, <xref ref-type="bibr" rid="hnpcc.REF.ou.2009.340">Ou et al 2009</xref>, <xref ref-type="bibr" rid="hnpcc.REF.duraturo.2011.1643">Duraturo et al 2011</xref>]. A succinct discussion of the evidence for a possible role of these genes in Lynch syndrome can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org">www.omim.org</ext-link>:</p>
            <list list-type="bullet">
              <list-item>
                <p><italic toggle="yes">MLH3</italic>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604395">604395</ext-link></p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">MSH3</italic>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600887">600887</ext-link></p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">EXO1</italic>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/606063">606063</ext-link></p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">PMS1</italic>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600258">600258</ext-link></p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">TGFBR2</italic>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/190182">190182</ext-link></p>
              </list-item>
            </list>
            <p>The clinical utility of testing for germline variants in these genes in individuals suspected of having Lynch syndrome is unknown.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <table-wrap id="hnpcc.T.summary_of_germline_molecular_ge" position="anchor" orientation="portrait">
              <label>Table 3. </label>
              <caption>
                <p>Summary of Germline Molecular Genetic Testing Used in Lynch Syndrome</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Proportion of Lynch Syndrome Attributed to Pathogenic Variants in This Gene</th>
                    <th id="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MLH1</italic>
                    </td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">50%&#x000a0;<sup>2,&#x000a0;3</sup></td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MSH2</italic>
                    </td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">40%&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MSH6</italic>
                    </td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">7%-10%&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">PMS2</italic>
                    </td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">&#x0003c;5%&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4,&#x000a0;10</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;10</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">EPCAM</italic><break/>(<italic toggle="yes">TACSTD1</italic>)</td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">~1%-3%&#x000a0;<sup>9</sup></td>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_hnpcc.T.summary_of_germline_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;6,&#x000a0;11</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="hnpcc.TF.3.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="hnpcc" object-id="hnpcc.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="hnpcc.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="hnpcc.TF.3.2">
                  <label>2. </label>
                  <p>
                    <xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2003.1174">Peltom&#x000e4;ki [2003]</xref>
                  </p>
                </fn>
                <fn id="hnpcc.TF.3.3">
                  <label>3. </label>
                  <p>Constitutional inactivation of <italic toggle="yes">MLH1</italic> by methylation, along with somatic loss of heterozygosity of the functional allele, has been reported to be a rare cause of Lynch syndrome. Such cases are not detectable by either sequence analysis or duplication/deletion analysis of <italic toggle="yes">MLH1</italic> (see <xref ref-type="sec" rid="hnpcc.Molecular_Genetics">Molecular Genetics</xref>).</p>
                </fn>
                <fn id="hnpcc.TF.3.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="hnpcc.TF.3.5">
                  <label>5. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="hnpcc.TF.3.6">
                  <label>6. </label>
                  <p>Large deletions and genetic rearrangements account for 20% of pathogenic variants in <italic toggle="yes">MSH2</italic>, 5% of pathogenic variants in <italic toggle="yes">MLH1</italic>, 20% of pathogenic variants in <italic toggle="yes">PMS2</italic>, and 7% of pathogenic variants in <italic toggle="yes">MSH6</italic>, and 100% of pathogenic variants in <italic toggle="yes">EPCAM</italic> [<xref ref-type="bibr" rid="hnpcc.REF.wijnen.1998.326">Wijnen et al 1998</xref>, <xref ref-type="bibr" rid="hnpcc.REF.charbonnier.2000.2760">Charbonnier et al 2000</xref>, <xref ref-type="bibr" rid="hnpcc.REF.wagner.2003.1088">Wagner et al 2003</xref>, <xref ref-type="bibr" rid="hnpcc.REF.plaschke.2004.4486">Plaschke et al 2004</xref>, <xref ref-type="bibr" rid="hnpcc.REF.senter.2008.419">Senter et al 2008</xref>].</p>
                </fn>
                <fn id="hnpcc.TF.3.7">
                  <label>7. </label>
                  <p><xref ref-type="bibr" rid="hnpcc.REF.miyaki.1997.271">Miyaki et al [1997]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.berends.2002.26">Berends et al [2002]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2003.1174">Peltom&#x000e4;ki [2003]</xref></p>
                </fn>
                <fn id="hnpcc.TF.3.8">
                  <label>8. </label>
                  <p>
                    <xref ref-type="bibr" rid="hnpcc.REF.senter.2008.419">Senter et al [2008]</xref>
                  </p>
                </fn>
                <fn id="hnpcc.TF.3.9">
                  <label>9. </label>
                  <p><xref ref-type="bibr" rid="hnpcc.REF.niessen.2009.737">Niessen et al [2009]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.goel.2011.869">Goel et al [2011]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.kuiper.2011.407">Kuiper et al [2011]</xref></p>
                </fn>
                <fn id="hnpcc.TF.3.10">
                  <label>10. </label>
                  <p>Due to the high level of homology between <italic toggle="yes">PMS2</italic> and pseudogenes, testing and interpretation of findings in this gene is difficult. A laboratory that adheres to ACMG guidelines for analysis of <italic toggle="yes">PMS2</italic> and that has expertise in testing this gene should be selected when a <italic toggle="yes">PMS2</italic> pathogenic variant is suspected in a family [<xref ref-type="bibr" rid="hnpcc.REF.hegde.2014.101">Hegde et al 2014</xref>].</p>
                </fn>
                <fn id="hnpcc.TF.3.11">
                  <label>11. </label>
                  <p>Germline deletions of <italic toggle="yes">EPCAM</italic> result in silencing of the adjacent <italic toggle="yes">MSH2</italic> allele by hypermethylation. The adjacent <italic toggle="yes">MSH2</italic> allele itself is not mutated (see <xref ref-type="sec" rid="hnpcc.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Test characteristics.</bold> See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533316/">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="hnpcc.REF.rahner.2013">Rahner et al 2013</xref>] for information on test characteristics including sensitivity and specificity.</p>
          </sec>
        </sec>
        <sec id="hnpcc.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis of Lynch syndrome in a proband.</bold> To view the Colorectal Cancer Screening testing strategy guidelines developed by the National Comprehensive Cancer Network (NCCN), click <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#colorectal_screening">here</ext-link> (no-fee registration and login required). Testing is ideally performed in a stepwise manner.</p>
          <sec id="hnpcc.secI">
            <label>I</label>
            <title>Testing of Tumor Tissue (<xref ref-type="table" rid="hnpcc.T.summary_of_tumor_tissue_test_res">Table 2</xref>)</title>
            <p>MSI and IHC allow for the screening of tumor tissue to help identify individuals who may have Lynch syndrome. These methods may be implemented with various strategies:</p>
            <p><bold>Approach 1.</bold> Screen all colorectal cancers with MSI and/or IHC testing [<xref ref-type="bibr" rid="hnpcc.REF.egapp.2009.35">EGAPP 2009</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>A 2005 population-based study of 1566 colorectal cancers reported that 25% of individuals found to have a germline pathogenic variant in an MMR gene did not meet the Amsterdam Criteria or Bethesda Guidelines, and therefore a broad-reaching strategy such as universal testing of all diagnosed individuals could be considered.</p>
              </list-item>
              <list-item>
                <p>Studies have shown that this strategy is increasingly being adopted by academic medical centers and to a lesser extent community hospitals [<xref ref-type="bibr" rid="hnpcc.REF.beamer.2012.1058">Beamer et al 2012</xref>].</p>
              </list-item>
              <list-item>
                <p>Because Lynch syndrome accounts for a similar proportion of endometrial cancer as colon cancer, universal screening programs are expanding to include routine analysis of newly diagnosed individuals with endometrial cancer as well [<xref ref-type="bibr" rid="hnpcc.REF.resnick.2009.530">Resnick et al 2009</xref>, <xref ref-type="bibr" rid="hnpcc.REF.moline.2013.121">Moline et al 2013</xref>].</p>
              </list-item>
              <list-item>
                <p>Success of such programs to identify individuals and families with Lynch syndrome largely depends on the systems in place for following up on abnormal results and ensuring follow through with appropriate genetic counseling and testing [<xref ref-type="bibr" rid="hnpcc.REF.heald.2013.1336">Heald et al 2013</xref>].</p>
              </list-item>
              <list-item>
                <p>The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.lynchscreening.net/">Lynch Syndrome Screening Network</ext-link> was established to help develop best practice approaches for universal screening and to collect long-term data on the outcomes of these programs.</p>
              </list-item>
            </list>
            <p>Note: While a combined approach of IHC and MSI testing of tumor tissue is ideal, use of IHC testing alone may be more feasible for large-scale screening programs because it is more readily available than MSI testing and provides information about which MMR gene most likely harbors a germline pathogenic variant. For example, for tumors exhibiting loss of both MLH1 and PMS2 expression, reflex testing of tumor tissue for <italic toggle="yes">MLH1</italic> promoter methylation and <italic toggle="yes">BRAF</italic> V600E variants can help distinguish sporadic tumors from those more likely to harbor a germline <italic toggle="yes">MLH1</italic> pathogenic variant.</p>
            <p><bold>Approach 2.</bold> Target IHC and/or MSI testing of tumor tissue from individuals with colorectal cancer or other Lynch syndrome-related cancers and additional features that suggest the diagnosis, such as early age of onset or strong family history.</p>
            <list list-type="bullet">
              <list-item>
                <p>Research continues to identify factors that may help distinguish the subset of individuals with colorectal and endometrial cancer at greatest risk for Lynch syndrome in order to minimize the costs of screening programs.</p>
              </list-item>
              <list-item>
                <p>The Bethesda Guidelines were established to help identify individuals who may have Lynch syndrome and who are candidates for MSI and/or IHC testing of tumor tissue [<xref ref-type="bibr" rid="hnpcc.REF.umar.2004.261">Umar et al 2004</xref>]. Although their estimated sensitivity in identifying individuals with Lynch syndrome is up to 94%, their specificity is only 25% [<xref ref-type="bibr" rid="hnpcc.REF.syngal.2000.641">Syngal et al 2000</xref>].</p>
              </list-item>
              <list-item>
                <p>Age of onset and pathologic features have also been used to predict which individuals most likely harbor an MMR pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.rabban.2014.793">Rabban et al 2014</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="hnpcc.secII">
            <label>II</label>
            <title>Molecular Genetic Testing (<xref ref-type="table" rid="hnpcc.T.summary_of_germline_molecular_ge">Table 3</xref>)</title>
            <p><bold>Approach 1.</bold> As recommended by the results of tumor testing (<xref ref-type="table" rid="hnpcc.T.summary_of_tumor_tissue_test_res">Table 2</xref>)</p>
            <p><bold>Approach 2.</bold> As per one of the following risk assessment models that help predict the likelihood of identifying a germline pathogenic variant in one of the Lynch syndrome associated genes</p>
            <list list-type="bullet">
              <list-item>
                <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://premm.dfci.harvard.edu/">PREMM<sub>1,2, 6</sub> Model</ext-link> is based on data from 4539 individuals undergoing genetic testing of <italic toggle="yes">MSH2, MLH1,</italic> and <italic toggle="yes">MSH6</italic> through a commercial laboratory. This model incorporates information on the Lynch syndrome-related cancers (colon, endometrial, stomach, ovarian, small intestine, urinary tract/kidney, bile ducts, glioblastoma, sebaceous gland tumors, and pancreas) in the proband and in first and second-degree relatives, and age of onset. Data from MSI and IHC testing are not included. Based on genotype/phenotype data, this model provides specific estimates of the likelhood of detecting a pathogenic variant in each of the MMR genes. Using a 5% mutation probability as a standard for MMR testing, the model has an estimated sensitivity of 90% and a specificity of 54% [<xref ref-type="bibr" rid="hnpcc.REF.kastrinos.2011.73">Kastrinos et al 2011</xref>]. The model is also able to use family history to estimate the likelihood that a person who has not had cancer has a pathogenic variant in an MRR gene.</p>
              </list-item>
              <list-item>
                <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://hnpccpredict.hgu.mrc.ac.uk/">MMRpredict</ext-link> is based on data from a population-based cohort diagnosed with colorectal cancer before age 55 years who were tested for pathogenic variants in <italic toggle="yes">MLH1, MSH2</italic>, and <italic toggle="yes">MSH6</italic>. Data from MSI and IHC testing and the presence of colorectal and/or endometrial cancer in first-degree relatives can be incorporated. This model can only be used in affected individuals; it is unclear how accurate the model is for tumors diagnosed in older individuals [<xref ref-type="bibr" rid="hnpcc.REF.barnetson.2006.2751">Barnetson et al 2006</xref>].</p>
              </list-item>
              <list-item>
                <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://bcb.dfci.harvard.edu/bayesmendel/mmrpro.php">MMRpro</ext-link> (see also <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www4.utsouthwestern.edu/breasthealth/cagene">CancerGene</ext-link> [registration required]) incorporates information on colorectal and endometrial cancers in the proband and first- and second-degree relatives, age of onset, and results of IHC and MSI testing to estimate the likelihood of identifying a germline pathogenic variant in <italic toggle="yes">MLH1</italic>, <italic toggle="yes">MSH2</italic>, or <italic toggle="yes">MSH6</italic> in a family; uses mendelian modeling to determine the probably that a family member has inherited a germline pathogenic variant; and calculates the individual&#x02019;s risk of developing colon and endometrial cancer. Pathogenic variant data have been obtained from clinic- and population-based data reported in the literature; cancer risk estimates are based on penetrance data from a meta-analysis of five large Lynch syndrome studies. Since this model does not incorporate information on most extracolonic cancers, it is unclear how accurately it can identify the gene most likely to be mutated [<xref ref-type="bibr" rid="hnpcc.REF.chen.2006.1479">Chen et al 2006</xref>].</p>
              </list-item>
            </list>
            <p><bold>Approach 3.</bold> Foregoing MSI testing and proceeding directly to germline molecular genetic testing in families meeting the Amsterdam Criteria. This approach is becoming more cost effective as next-generation sequencing reduces the cost of testing all MMR genes and <italic toggle="yes">EPCAM</italic>. However, because there are substantial differences in cancer risk estimates between families with MMR-deficient colon cancer versus MMR-proficient cancers, tumor tissue is often still part of a comprehensive evaluation [<xref ref-type="bibr" rid="hnpcc.REF.bapat.2009.967">Bapat et al 2009</xref>]. Direct genetic testing of the MMR genes can be considered in the following situations.</p>
            <p>When no tumor tissue is available for tumor testing:</p>
            <list list-type="bullet">
              <list-item>
                <p>One strategy for molecular diagnosis of Lynch syndrome is sequential single-gene molecular genetic testing.</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Molecular testing should begin with a family member diagnosed with a Lynch syndrome-related cancer.</p>
                  </list-item>
                  <list-item>
                    <p>Pursue molecular testing of all four MMR genes and <italic toggle="yes">EPCAM</italic>. Testing can be done in a stepwise manner beginning with the genes in which a pathogenic variant is most likely to be identified.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Another strategy is use of a multi-gene panel that evaluates all MRR genes simultaneously. Note: Colon cancer panels may include additional genes not associated with Lynch syndrome.</p>
                <list list-type="bullet">
                  <list-item>
                    <p>The use of a multi-gene panel may provide for efficient identification of pathogenic variants in situations when tumor testing cannot be done to help narrow down the gene involved.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>If no germline pathogenic variant is identified in any one of the five genes tested, Lynch syndrome still cannot be ruled out because some pathogenic variants may be missed, or it is possible that the family member selected for testing had a sporadic (non-genetic) cancer. In this latter instance, molecular genetic testing of another relative with a Lynch syndrome-related cancer may result in detection of a causative germline variant.</p>
              </list-item>
              <list-item>
                <p>In the absence of information on the MSI status of the tumor, it is not possible to distinguish between Lynch syndrome and other causes of familial colorectal cancer.</p>
              </list-item>
            </list>
            <p>When no tumor tissue or living affected relative is available for testing:</p>
            <list list-type="bullet">
              <list-item>
                <p>Molecular genetic testing to identify a germline pathogenic variant could be pursued in an unaffected family member.</p>
              </list-item>
              <list-item>
                <p>The likelihood of an unaffected person having a pathogenic variant (if one is present in the family) depends on that individual's degree of relatedness to an affected family member (e.g., a first-degree relative has a 50% chance of having inherited a pathogenic variant).</p>
              </list-item>
              <list-item>
                <p>A cost-benefit analysis suggests that testing unaffected individuals is worth pursuing in such instances because of the significant benefit for the family if a Lynch syndrome-causing germline variant is identified [<xref ref-type="bibr" rid="hnpcc.REF.dinh.2011.9">Dinh et al 2011</xref>].</p>
              </list-item>
            </list>
          </sec>
        </sec>
      </sec>
      <sec id="hnpcc.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="hnpcc.Clinical_Description">
          <title>Clinical Description</title>
          <p>Individuals with Lynch syndrome caused by a germline pathogenic variant in a mismatch repair gene or associated with tumors exhibiting MSI are at increased risk for colon cancer and other cancers including cancers of the endometrium, ovary, stomach, small intestine, hepatobiliary tract, upper urinary tract, brain, and skin (<xref ref-type="table" rid="hnpcc.T.cancer_risks_in_individuals_with">Table 4</xref>).</p>
          <table-wrap id="hnpcc.T.cancer_risks_in_individuals_with" position="anchor" orientation="portrait">
            <label>Table 4. </label>
            <caption>
              <p>Cancer Risks in Individuals with Lynch Syndrome Age &#x02264;70 Years Compared to the General Population</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1">Cancer Type</th>
                  <th id="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2">General Population Risk</th>
                  <th id="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Lynch Syndrome<break/>(<italic toggle="yes">MLH1</italic> and <italic toggle="yes">MSH2</italic> heterozygotes)</th>
                </tr>
                <tr>
                  <th headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3" id="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Risk</th>
                  <th headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3" id="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mean Age of Onset</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Colon</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4.8%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">52%-82%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">44-61 years</td>
                </tr>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Endometrium</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2.7%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">25%-60%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">48-62 years</td>
                </tr>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Stomach</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">6%-13%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">56 years</td>
                </tr>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Ovary</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1.4%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">4%-12%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">42.5 years</td>
                </tr>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hepatobiliary tract</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1.4%-4%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Not reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Urinary tract</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1%-4%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~55 years</td>
                </tr>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Small bowel</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">3%-6%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">49 years</td>
                </tr>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Brain/central nervous system</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1%-3%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~50 years</td>
                </tr>
                <tr>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Sebaceous neoplasms</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1%-9%</td>
                  <td headers="hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_1_3 hd_h_hnpcc.T.cancer_risks_in_individuals_with_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Not reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p><xref ref-type="bibr" rid="hnpcc.REF.aarnio.1999.214">Aarnio et al [1999]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.vasen.2001.4074">Vasen et al [2001]</xref>, <xref ref-type="bibr" rid="hnpcc.REF16">American Cancer Society [2002]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.hampel.2005.415">Hampel et al [2005]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.ponti.2006.2302">Ponti et al [2006]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.south.2008.277">South et al [2008]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.watson.2008.444">Watson et al [2008]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.barrow.2009.141">Barrow et al [2009]</xref>, <xref ref-type="bibr" rid="hnpcc.REF.stoffel.2009.1621">Stoffel et al [2009]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Colon cancer.</bold> Initial studies based on high-risk kindreds meeting Amsterdam criteria have found up to an 82% lifetime risk for colon cancer, and a mean age of onset of 44 years. Two thirds of these cancers occur in the proximal colon [<xref ref-type="bibr" rid="hnpcc.REF.lynch.1993.1535">Lynch et al 1993</xref>, <xref ref-type="bibr" rid="hnpcc.REF.lynch.1996.1149">Lynch &#x00026; Smyrk 1996</xref>, <xref ref-type="bibr" rid="hnpcc.REF.aarnio.1999.214">Aarnio et al 1999</xref>].</p>
          <p>More recent studies of heterozygotes for an <italic toggle="yes">MLH1</italic> and <italic toggle="yes">MSH2</italic> pathogenic variant have resulted in lower risk estimates of 66%-69% for men and 43%-52% for women, and an average age of diagnosis of 61 years [<xref ref-type="bibr" rid="hnpcc.REF.hampel.2005.415">Hampel et al 2005</xref>, <xref ref-type="bibr" rid="hnpcc.REF.stoffel.2009.1621">Stoffel et al 2009</xref>].</p>
          <p>Colon cancer risk estimates have also been lower for heterozygotes for an <italic toggle="yes">MSH6</italic> and <italic toggle="yes">PMS2</italic> pathogenic variant. Risks to male and female heterozygotes for an <italic toggle="yes">MSH6</italic> pathogenic variant up to age 80 years have been found to be 44% and 20%, respectively. While substantially lower than the risk associated with <italic toggle="yes">MLH1</italic> and <italic toggle="yes">MHS2</italic> pathogenic variants, this still represents an eightfold increase in colon cancer risk [<xref ref-type="bibr" rid="hnpcc.REF.baglietto.2010.193">Baglietto et al 2010</xref>]. The risk to heterozygotes for a <italic toggle="yes">PMS2</italic> pathogenic variant up to age 70 years was 15%-20% [<xref ref-type="bibr" rid="hnpcc.REF.senter.2008.419">Senter et al 2008</xref>].</p>
          <p>Data on cancer risks for those with an <italic toggle="yes">EPCAM</italic> pathogenic variant is still limited, but <xref ref-type="bibr" rid="hnpcc.REF.kempers.2011.49">Kempers et al [2011]</xref> reported on findings from 194 individuals with an <italic toggle="yes">EPCAM</italic> deletion. From this cohort they estimated a 75% (95% CI 65-86) cumulative incidence of colorectal cancer by age 70 years. The risk for colorectal cancer did not differ between those who had only a 3&#x02019; deletion of <italic toggle="yes">EPCAM</italic> and those harboring a deletion that encompassed <italic toggle="yes">EPCAM</italic> and <italic toggle="yes">MSH2.</italic></p>
          <p>When matched stage for stage, colon cancers in individuals with Lynch syndrome are associated with a better prognosis than sporadic colon cancers [<xref ref-type="bibr" rid="hnpcc.REF.watson.1998.259">Watson et al 1998</xref>], an unexpected finding because the poorly differentiated histology of Lynch syndrome-related colon cancers is typically associated with a poor prognosis. Histologic characteristics of Lynch syndrome-related colon cancers include: poor differentiation, tumor-infiltrating lymphocytes, mucin, and signet ring or cribiform histology.</p>
          <p><bold>Endometrial cancer.</bold> Women with Lynch syndrome have a 25%-60% lifetime risk of endometrial cancer, making this the second most common cancer in Lynch syndrome [<xref ref-type="bibr" rid="hnpcc.REF.aarnio.1999.214">Aarnio et al 1999</xref>, <xref ref-type="bibr" rid="hnpcc.REF.vasen.2001.4074">Vasen et al 2001</xref>, <xref ref-type="bibr" rid="hnpcc.REF.hampel.2005.415">Hampel et al 2005</xref>, <xref ref-type="bibr" rid="hnpcc.REF.stoffel.2008.470">Stoffel et al 2008</xref>]. Studies based on high-risk families have found an average age of diagnosis of approximately 48 years; population-based studies have revealed a later age of diagnosis (62 years) [<xref ref-type="bibr" rid="hnpcc.REF.vasen.1994.1675">Vasen et al 1994</xref>, <xref ref-type="bibr" rid="hnpcc.REF.hampel.2005.415">Hampel et al 2005</xref>].</p>
          <p>While mutation of <italic toggle="yes">MSH6</italic> is associated with a more moderately increased colon cancer risk, heterozygotes have a 44% risk for endometrial cancer, similar to the level of risk reported for <italic toggle="yes">MLH1</italic> and <italic toggle="yes">MSH2</italic> heterozygotes [<xref ref-type="bibr" rid="hnpcc.REF.baglietto.2010.193">Baglietto et al 2010</xref>]. Among women with Lynch syndrome who develop both colon cancer and endometrial cancer, approximately 50% present first with endometrial cancer [<xref ref-type="bibr" rid="hnpcc.REF.watson.1994.516">Watson et al 1994</xref>, <xref ref-type="bibr" rid="hnpcc.REF.lu.2005.569">Lu et al 2005</xref>]. The risk for subsequent endometrial cancer for women with Lynch syndrome presenting first with colon cancer has been estimated at 26% within ten years of the initial colon cancer diagnosis [<xref ref-type="bibr" rid="hnpcc.REF.obermair.2010.2678">Obermair et al 2010</xref>].</p>
          <p>Kemper et al found a 12% (95% CI 0-27) cumulative risk for endometrial cancer by age 70 years. The risk for women with deletions affecting both <italic toggle="yes">EPCAM</italic> and <italic toggle="yes">MSH2</italic> was similar to that reported for women with an <italic toggle="yes">MSH2</italic> pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.kempers.2011.49">Kempers et al 2011</xref>].</p>
          <p>Overall, Lynch syndrome accounts for approximately 2% of all endometrial cancers [<xref ref-type="bibr" rid="hnpcc.REF.hampel.2006.7810">Hampel et al 2006</xref>]. A survival advantage similar to that in Lynch syndrome-related colon cancer has been reported in Lynch syndrome-related endometrial cancers [<xref ref-type="bibr" rid="hnpcc.REF.maxwell.2001.417">Maxwell et al 2001</xref>].</p>
          <p><bold>Gastric cancer.</bold> Estimates for gastric cancer risk in heterozygotes for an <italic toggle="yes">MLH1</italic> or an <italic toggle="yes">MSH2</italic> pathogenic variant range from 6% to 13%. The risk is greatest in males with an <italic toggle="yes">MSH2</italic> pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.watson.2008.444">Watson et al 2008</xref>, <xref ref-type="bibr" rid="hnpcc.REF.capelle.2010.487">Capelle et al 2010</xref>]. Higher risks have been reported in countries with other risk factors for gastric cancer such as high incidence of <italic toggle="yes">H pylori</italic> infection [<xref ref-type="bibr" rid="hnpcc.REF.park.2000.2994">Park et al 2000</xref>]. The mean age of diagnosis of gastric cancer is 56 years. Intestinal-type adenocarcinoma, the most commonly reported pathology of Lynch syndrome-related gastric cancers [<xref ref-type="bibr" rid="hnpcc.REF.aarnio.1997.551">Aarnio et al 1997</xref>], differs histologically from the diffuse gastric cancer that is most commonly seen in <related-object link-type="booklink" source-id="gene" document-id="hgc" document-type="chapter">hereditary diffuse gastric cancer</related-object> caused by pathogenic variants in <italic toggle="yes">CDH1</italic> [<xref ref-type="bibr" rid="hnpcc.REF.guilford.1999.249">Guilford et al 1999</xref>]. However, Capelle et al reported that up to 20% of Lynch syndrome-related gastric cancers may be the diffuse type [<xref ref-type="bibr" rid="hnpcc.REF.capelle.2010.487">Capelle et al 2010</xref>].</p>
          <p><bold>Ovarian cancer.</bold> The risk for ovarian cancer varies by the MMR gene in which germline mutation occurs. The risk to heterozygotes for an <italic toggle="yes">MLH1</italic> pathogenic variant has been found to be 4%-6%, while <italic toggle="yes">MSH2</italic> heterozygotes have an 8%-11% risk. The mean age of diagnosis of Lynch syndrome-associated ovarian cancers is 42.5 years; however, diagnosis at very young ages has been reported. Approximately 30% of Lynch syndrome-associated ovarian cancers are diagnosed before age 35 years [<xref ref-type="bibr" rid="hnpcc.REF.watson.2008.444">Watson et al 2008</xref>].</p>
          <p>The distribution of pathology types is similar to that seen in sporadic ovarian cancers. Borderline ovarian tumors do not seem to be associated with Lynch syndrome [<xref ref-type="bibr" rid="hnpcc.REF.watson.2001.223">Watson et al 2001</xref>].</p>
          <p><bold>Other cancers.</bold> Other Lynch syndrome-related cancers that have characteristic features have been reported:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Urinary tract cancers</bold>. The urinary tract cancers most commonly associated with Lynch syndrome are transitional carcinomas of the ureter and renal pelvis. A recent study suggests that bladder cancer risk is likely also increased in Lynch syndrome. A study of a Dutch Lynch syndrome cohort demonstrated a relative risk for bladder cancer of 4.4 for males and 2.2 for females; the majority of tumor tissue available for MSI and/or IHC testing exhibited MSI and/or had loss of protein expression corresponding to the germline variant [<xref ref-type="bibr" rid="hnpcc.REF.van_der_post.2010.464">van der Post et al 2010</xref>]. Another study of individuals with Lynch syndrome and a prior diagnosis of colorectal cancer also demonstrated an increased risk for bladder cancer (7.22, 95% CI=4.08-10.99) and other urinary tract cancers (kidney, renal pelvis, and ureter) (12.54, 95% CI 7.97-17.94) providing additional evidence that bladder cancer should be included in the Lynch syndrome cancer spectrum [<xref ref-type="bibr" rid="hnpcc.REF.win.2013.1578">Win et al 2013</xref>].Risk estimates for urinary tract cancers vary significantly based on gender and the mutated gene, with higher risks seen in males heterozygous for an <italic toggle="yes">MSH2</italic> pathogenic variant. Women with an <italic toggle="yes">MLH1</italic> pathogenic variant have an approximately 1% risk while men with an <italic toggle="yes">MSH2</italic> pathogenic variant have been estimated to have up to a 27% risk [<xref ref-type="bibr" rid="hnpcc.REF.watson.2008.444">Watson et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Small bowel cancer.</bold> The risk for small bowel cancer has been estimated at between 3% and 6% [<xref ref-type="bibr" rid="hnpcc.REF.watson.2008.444">Watson et al 2008</xref>]. The duodenum and jejunum are the most common sites for small bowel cancers, with approximately 50% in reach of upper endoscopy [<xref ref-type="bibr" rid="hnpcc.REF.schulmann.2005.590">Schulmann et al 2005</xref>]. The majority of small bowel cancers are adenocarcinomas [<xref ref-type="bibr" rid="hnpcc.REF.rodriguezbigas.1998.240">Rodriguez-Bigas et al 1998</xref>, <xref ref-type="bibr" rid="hnpcc.REF.schulmann.2005.590">Schulmann et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Pancreatic cancer.</bold> A study by <xref ref-type="bibr" rid="hnpcc.REF.kastrinos.2009.1790">Kastrinos et al [2009]</xref> based on reported family history found an 8.6-fold increased risk up to age 70 years for pancreatic cancer [<xref ref-type="bibr" rid="hnpcc.REF.kastrinos.2009.1790">Kastrinos et al 2009</xref>]. A prospective study which followed 446 individuals with an MMR pathogenic variant and 1029 relatives for a median of five years found an increased risk for pancreatic cancer (SIR, 10.68; 95% CI 2.68-47.70), and no increased risk for individuals without a pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.win.2012.958">Win et al 2012</xref>]. However, other studies have not demonstrated an increased risk [<xref ref-type="bibr" rid="hnpcc.REF.barrow.2009.141">Barrow et al 2009</xref>]. Lynch syndrome has been found to be a rare cause of familial pancreatic cancer [<xref ref-type="bibr" rid="hnpcc.REF.gargiulo.2009.547">Gargiulo et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Brain tumors.</bold> The risk for brain tumors is estimated at approximately 2% [<xref ref-type="bibr" rid="hnpcc.REF.schulmann.2005.590">Schulmann et al 2005</xref>]. However, <xref ref-type="bibr" rid="hnpcc.REF.barrow.2009.141">Barrow et al [2009]</xref> estimated a 16-fold increased risk for persons with biallelic <italic toggle="yes">MSH2</italic> pathogenic variants. The most common type of central nervous system tumor is glioblastoma [<xref ref-type="bibr" rid="hnpcc.REF.hamilton.1995.839">Hamilton et al 1995</xref>, <xref ref-type="bibr" rid="hnpcc.REF.wimmer.2008.105">Wimmer &#x00026; Etzler 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Sebaceous skin neoplasias</bold> described include: sebaceous adenomas, sebaceous epitheliomas, sebaceous carcinomas, and keratoacanthomas [<xref ref-type="bibr" rid="hnpcc.REF.schwartz.1995.90">Schwartz &#x00026; Torre 1995</xref>, <xref ref-type="bibr" rid="hnpcc.REF.misago.2000.155">Misago &#x00026; Narisawa 2000</xref>]. Sebaceous neoplasms associated with Lynch syndrome exhibit MSI [<xref ref-type="bibr" rid="hnpcc.REF.entius.2000.1784">Entius et al 2000</xref>, <xref ref-type="bibr" rid="hnpcc.REF.machin.2002.415">Machin et al 2002</xref>]. The data on the frequency of sebaceous neoplasms in individuals with Lynch syndrome are limited. Studies have found that between 1% and 9% of individuals with a germline pathogenic variant in an MMR gene have a sebaceous neoplasm [<xref ref-type="bibr" rid="hnpcc.REF.ponti.2006.2302">Ponti et al 2006</xref>, <xref ref-type="bibr" rid="hnpcc.REF.south.2008.277">South et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Prostate cancer.</bold> Several studies have demonstrated an association with prostate cancer, with the increase in risk ranging from two- to nearly fivefold [<xref ref-type="bibr" rid="hnpcc.REF.raymond.2013b.1713">Raymond et al 2013b</xref>, <xref ref-type="bibr" rid="hnpcc.REF.haraldsdottir.2014.553">Haraldsdottir et al 2014</xref>, <xref ref-type="bibr" rid="hnpcc.REF.ryan.2014.437">Ryan et al 2014</xref>]. <xref ref-type="bibr" rid="hnpcc.REF.raymond.2013b.1713">Raymond et al [2013b]</xref> found that the risk for prostate cancer was increased for men with an MMR pathogenic variant prior to age 60 [<xref ref-type="bibr" rid="hnpcc.REF.raymond.2013b.1713">Raymond et al 2013b</xref>], whereas an analysis by <xref ref-type="bibr" rid="hnpcc.REF.haraldsdottir.2014.553">Haraldsdottir et al [2014]</xref> found earlier age of onset or a more aggressive phenotype in the prostate cancers occurring in individuals with an MMR pathogenic variant.</p>
            </list-item>
            <list-item>
              <p><bold>Breast cancer.</bold> The relationship between breast cancer and Lynch syndrome is unresolved. A systematic review evaluated 21 studies; 13 did not demonstrate an increased risk for breast cancer in individuals with Lynch syndrome and eight did show an increased risk [<xref ref-type="bibr" rid="hnpcc.REF.win.2013.1578">Win et al 2013</xref>]. To date, breast cancer risk has only been evaluated in one prospective study. Individuals with a pathogenic variant were found to have a standard incidence ratio for breast cancer of 3.95 (95% CI 1.59-8.13), and the median age of breast cancer diagnosis was 56 years. A study by <xref ref-type="bibr" rid="hnpcc.REF.walsh.2010.2214">Walsh et al [2010]</xref> determined that tissue from 51% of breast cancers in individuals with a pathogenic variant in an MMR gene exhibited loss of immunohistochemical staining for the protein corresponding to the gene in which germline mutation occurs. Due to the high frequency of breast cancer in the general population, the presence of sporadic breast cancers complicates analysis of the association with Lynch syndrome.</p>
            </list-item>
            <list-item>
              <p><bold>Additional cancer risks.</bold> Several other cancer types have been reported to occur in individuals with Lynch syndrome. In some cases, MSI and/or IHC testing of tumor tissue demonstrated concordance between the extra-colonic cancer and the mutation status of the affected individual. While these types of findings suggest that the underlying presence of a pathogenic variant in an MMR gene contributed to the development of the cancer, data are not sufficient to demonstrate that the risk of developing these types of cancers is increased in individuals with Lynch syndrome.Several types of sarcomas have been reported in individuals with an MMR pathogenic variant, including fibrous histiocytomas, rhabdomyosarcomas, leiomyosarcoma and liposarcoma [<xref ref-type="bibr" rid="hnpcc.REF.sijmons.2000.353">Sijmons et al 2000</xref>, <xref ref-type="bibr" rid="hnpcc.REF.den_bakker.2003.297">den Bakker et al 2003</xref>, <xref ref-type="bibr" rid="hnpcc.REF.nilbert.2009.209">Nilbert et al 2009</xref>]. <xref ref-type="bibr" rid="hnpcc.REF.nilbert.2009.209">Nilbert et al [2009]</xref> determined that six of eight sarcomas in individuals with Lynch syndrome exhibited defective MMR, suggesting that sarcomas may also be part of the spectrum of Lynch syndrome tumors. Due to the rarity of sarcomas it may be difficult to determine the magnitude of risk associated with Lynch syndrome. Adrenocortical carcinoma (ACC) has also been reported in families with Lynch syndrome. The most extensive study of this association performed through a hereditary cancer clinic at the University of Michigan found two of 114 (1.7%) individuals presenting with ACC had a family history consistent with Lynch syndrome and had an MMR pathogenic variant identified. This association was further evaluated by case review of 135 individuals with pathogenic MMR variants, which identified two (1.4%) individuals who also had ACC [<xref ref-type="bibr" rid="hnpcc.REF.raymond.2013a.3012">Raymond et al 2013a</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Lynch syndrome variants</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Muir-Torre syndrome</bold> is defined by the combination of sebaceous neoplasms of the skin and one or more internal malignancies, commonly those seen in Lynch syndrome. The types of sebaceous skin neoplasias described include: sebaceous adenomas, sebaceous epitheliomas, sebaceous carcinomas, and keratoacanthomas [<xref ref-type="bibr" rid="hnpcc.REF.schwartz.1995.90">Schwartz &#x00026; Torre 1995</xref>, <xref ref-type="bibr" rid="hnpcc.REF.misago.2000.155">Misago &#x00026; Narisawa 2000</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Turcot syndrome</bold> is defined as colorectal cancer or colorectal adenomas in addition to tumors of the central nervous system. The clinical presentation varies from numerous colonic polyps to a single polyp or colorectal cancer.Turcot syndrome is usually caused either by a pathogenic variant of <italic toggle="yes">APC</italic> (see <related-object link-type="booklink" source-id="gene" document-id="fap" document-type="chapter"><italic toggle="yes">APC</italic>-Associated Polyposis Conditions</related-object>) or by a pathogenic variant in one of the mismatch repair genes associated with Lynch syndrome [<xref ref-type="bibr" rid="hnpcc.REF.hamilton.1995.839">Hamilton et al 1995</xref>]. Individuals with an <italic toggle="yes">APC</italic> pathogenic variant typically have more polyps; however, a significant overlap in polyp number occurs between individuals with Turcot syndrome caused by an <italic toggle="yes">APC</italic> pathogenic variant and those with Turcot syndrome caused by a pathogenic variant in a mismatch repair gene [<xref ref-type="bibr" rid="hnpcc.REF.hamilton.1995.839">Hamilton et al 1995</xref>]. The pathology of the CNS tumor can help distinguish between the underlying genetic causes: <italic toggle="yes">APC</italic> pathogenic variants are more commonly associated with medulloblastoma; pathogenic variants in mismatch repair genes are more commonly associated with glioblastoma.The brain tumors associated with mutation of a mismatch repair gene exhibit MSI [<xref ref-type="bibr" rid="hnpcc.REF.hamilton.1995.839">Hamilton et al 1995</xref>, <xref ref-type="bibr" rid="hnpcc.REF.suzui.1998.126">Suzui et al 1998</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Homozygous mismatch repair variants.</bold> Rare individuals who are homozygous for pathogenic variants in <italic toggle="yes">MLH1</italic>, <italic toggle="yes">MSH2</italic>, <italic toggle="yes">MSH6,</italic> and <italic toggle="yes">PMS2</italic> have been reported. Affected individuals often have onset of colon or small bowel cancer prior to the second decade of life. One third of children with biallelic pathogenic variants in an MMR gene have been reported to have more than ten polyps. Hematologic cancer, brain tumors, and caf&#x000e9;-au-lait macules have also been reported [<xref ref-type="bibr" rid="hnpcc.REF.wimmer.2008.105">Wimmer &#x00026; Etzler 2008</xref>, <xref ref-type="bibr" rid="hnpcc.REF.durno.2010.2449">Durno et al 2010</xref>, <xref ref-type="bibr" rid="hnpcc.REF.bakry.2014.987">Bakry et al 2014</xref>]. The cutaneous phenotype in affected individuals may be remarkably similar to that seen in <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">neurofibromatosis type I</related-object> [<xref ref-type="bibr" rid="hnpcc.REF.wimmer.2012">Wimmer 2012</xref>]. However, it is more likely that individuals who are homozygous or compound heterozygous for a pathogenic variant in one of the genes causing Lynch syndrome have one or more of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Family history of Lynch syndrome</p>
                </list-item>
                <list-item>
                  <p>Consanguineous parents</p>
                </list-item>
                <list-item>
                  <p>At least one parent with clinical findings of Lynch syndrome</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="hnpcc.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Cancer risks vary among the four MMR genes.</p>
          <p>Heterozygosity for an <italic toggle="yes">MSH2</italic> pathogenic variant is associated with the greatest risk for extracolonic cancers; risk for extracolonic cancers (other than endometrial cancer) is low for heterozygotes with an <italic toggle="yes">MSH6</italic>, <italic toggle="yes">PMS2,</italic> or <italic toggle="yes">EPCAM</italic> pathogenic variant.</p>
          <p><italic toggle="yes">MSH2</italic> pathogenic variants have been reported more commonly than a pathogenic variant in the other three MMR genes in individuals with the Muir-Torre variant of Lynch syndrome [<xref ref-type="bibr" rid="hnpcc.REF.south.2008.277">South et al 2008</xref>].</p>
          <p>Heterozygosity for a pathogenic variant in <italic toggle="yes">MSH6</italic> is associated with MSI-low tumors. The cancers in families with an <italic toggle="yes">MSH6</italic> pathogenic variant may be later in onset and more distally located than the cancers in families with Lynch syndrome resulting from a pathogenic variant in one of the other MMR genes; endometrial cancer is commonly observed in women with an <italic toggle="yes">MSH6</italic> pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.wu.1999.1291">Wu et al 1999</xref>, <xref ref-type="bibr" rid="hnpcc.REF.berends.2002.26">Berends et al 2002</xref>]. Slightly lower risks for colon cancer and higher risks for endometrial cancer have been reported in families with an <italic toggle="yes">MSH6</italic> pathogenic variant than in families with an <italic toggle="yes">MLH1</italic> or <italic toggle="yes">MSH2</italic> pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.berends.2002.26">Berends et al 2002</xref>, <xref ref-type="bibr" rid="hnpcc.REF.baglietto.2010.193">Baglietto et al 2010</xref>].</p>
          <p>Heterozygosity for a <italic toggle="yes">PMS2</italic> pathogenic variant is associated with the lowest risk (25%-32% risk) for any Lynch syndrome-related cancer [<xref ref-type="bibr" rid="hnpcc.REF.senter.2008.419">Senter et al 2008</xref>].</p>
          <p>Deletions of <italic toggle="yes">EPCAM</italic> that result in epigenetic silencing of <italic toggle="yes">MSH2</italic> are associated with a significantly increased risk for colon cancer. Studies have shown high levels of <italic toggle="yes">EPCAM</italic> expression in colonic stem cells; however, because <italic toggle="yes">EPCAM</italic> is not expressed at high levels in all tissues, the effect of <italic toggle="yes">EPCAM</italic> on extracolonic cancer risks is unclear. <xref ref-type="bibr" rid="hnpcc.REF.kempers.2011.49">Kempers et al [2011]</xref> reported a low risk for endometrial cancer in those with deletions of <italic toggle="yes">EPCAM</italic> compared to mutation of an MMR gene. The risk for extra-colonic cancers also is dependent on the extent of the deletion. 3&#x02019; <italic toggle="yes">EPCAM</italic> deletions have been shown to confer a lower risk for extra-colonic cancers, whereas deletions that extend into <italic toggle="yes">MSH2</italic> confer extra-colonic cancer risks similar to intragenic <italic toggle="yes">MSH2</italic> pathogenic variants [<xref ref-type="bibr" rid="hnpcc.REF.tutlewska.2013.9">Tutlewska et al 2013</xref>].</p>
        </sec>
        <sec id="hnpcc.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance of colon cancer associated with mutation of an MMR gene or <italic toggle="yes">EPCAM</italic> is less than 100% (see <xref ref-type="table" rid="hnpcc.T.cancer_risks_in_individuals_with">Table 4</xref>). Therefore, some individuals with a cancer-predisposing pathogenic variant in one of the MMR genes never develop colon cancer.</p>
        </sec>
        <sec id="hnpcc.Anticipation">
          <title>Anticipation</title>
          <p>One study reporting anticipation in Lynch syndrome (i.e., offspring having a younger age of onset than the parents) [<xref ref-type="bibr" rid="hnpcc.REF.westphalen.2005.461">Westphalen et al 2005</xref>] has not been reproduced. Another study in which offspring had a younger age of onset than their parents determined that this observation was caused by birth cohort bias [<xref ref-type="bibr" rid="hnpcc.REF.tsai.1997.435">Tsai et al 1997</xref>].</p>
        </sec>
        <sec id="hnpcc.Nomenclature">
          <title>Nomenclature</title>
          <p>Lynch syndrome has also been called hereditary non-polyposis colorectal cancer (HNPCC). Clinicians and researchers working in the area of hereditary colon cancer have suggested returning to the use of the original name, Lynch syndrome, to specify individuals and families with defective MMR and to distinguish them from other forms of familial colon cancer [<xref ref-type="bibr" rid="hnpcc.REF.bellizzi.2009.405">Bellizzi &#x00026; Frankel 2009</xref>, <xref ref-type="bibr" rid="hnpcc.REF.weissman.2011.5">Weissman et al 2011</xref>].</p>
        </sec>
        <sec id="hnpcc.Prevalence">
          <title>Prevalence</title>
          <p>Lynch syndrome accounts for approximately 1%-3% of colon cancers, and 0.8%-1.4% of endometrial cancers [<xref ref-type="bibr" rid="hnpcc.REF.kowalski.1997.219">Kowalski et al 1997</xref>, <xref ref-type="bibr" rid="hnpcc.REF.chadwick.2001.461">Chadwick et al 2001</xref>, <xref ref-type="bibr" rid="hnpcc.REF.cunningham.2001.780">Cunningham et al 2001</xref>].</p>
          <p>The population prevalence of Lynch syndrome can be estimated at 1:440 [<xref ref-type="bibr" rid="hnpcc.REF.chen.2006.1479">Chen et al 2006</xref>].</p>
        </sec>
      </sec>
      <sec id="hnpcc.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">MLH1</italic>, <italic toggle="yes">MSH2</italic>, <italic toggle="yes">MSH6</italic>, <italic toggle="yes">PMS2</italic>, and <italic toggle="yes">EPCAM.</italic></p>
      </sec>
      <sec id="hnpcc.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Familial colorectal cancer.</bold> Evaluation of MSI status of tumor tissue is important for differentiating Lynch syndrome from familial colorectal cancer. In studies of families with strong histories of colorectal cancer whose tumors are MSI stable, no increased risk for the extracolonic cancers commonly associated with a germline pathogenic variant in a mismatch repair gene was identified. The risk for colorectal cancer also appears to be lower in families with MSI-stable tumors [<xref ref-type="bibr" rid="hnpcc.REF.abdelrahman.2005.1542">Abdel-Rahman et al 2005</xref>, <xref ref-type="bibr" rid="hnpcc.REF.lindor.2005.1979">Lindor et al 2005</xref>, <xref ref-type="bibr" rid="hnpcc.REF.muellerkoch.2005.1733">Mueller-Koch et al 2005</xref>]. Many candidate genes, low-penetrance alleles, and environmental risk factors have been evaluated with respect to their contributions to familial colorectal cancer.</p>
        <p><bold>Attenuated</bold>
<related-object link-type="booklink" source-id="gene" document-id="fap" document-type="chapter"><bold>familial adenomatous polyposis</bold></related-object>
<bold>(AFAP).</bold> This milder presentation of FAP, also caused by pathogenic variants in <italic toggle="yes">APC</italic>, is characterized by fewer polyps and later age of onset than classic FAP. In AFAP, typically fewer than 100 polyps are observed. Polyps of the gastric fundus and duodenum also occur; however, many of the extracolonic manifestations commonly observed in FAP (e.g., epidermal cysts, dental abnormalities, congenital hypertrophy of retinal pigmented epithelium, desmoid tumors) may be absent in AFAP. Polyps and colon cancers associated with AFAP do not usually exhibit MSI. AFAP is inherited in an autosomal dominant manner.</p>
        <p><bold>The <italic toggle="yes">APC</italic></bold>
<bold>p.Ile1307Lys pathogenic variant.</bold> This pathogenic missense variant is not associated with the classic FAP phenotype; however, individuals with the p.Ile1307Lys pathogenic variant in <italic toggle="yes">APC</italic> are at an approximately twofold increased risk for colon cancer. The variant is found in approximately 6% of individuals of Ashkenazi Jewish ancestry [<xref ref-type="bibr" rid="hnpcc.REF.laken.1997.79">Laken et al 1997</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="fap" document-type="chapter"><italic toggle="yes">APC</italic>-Associated Polyposis Conditions</related-object> for information on this variant.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="maps" document-type="chapter"><bold><italic toggle="yes">MUTYH</italic>-associated polyposis</bold></related-object><bold>.</bold> Pathogenic variants in <italic toggle="yes">MUTYH</italic> (<italic toggle="yes">MYH</italic>) have been described in individuals with multiple adenomatous polyps. Pathogenic variants in <italic toggle="yes">MUTYH</italic> have been identified in: (1) approximately 30% of individuals with 15-100 polyps; (2) a small portion of individuals with a classic FAP phenotype who have no identifiable <italic toggle="yes">APC</italic> pathogenic variant; and (3) individuals with a family history of colon cancer in the absence of multiple polyps [<xref ref-type="bibr" rid="hnpcc.REF.jo.2005.1022">Jo et al 2005</xref>]. Inheritance is autosomal recessive [<xref ref-type="bibr" rid="hnpcc.REF.sieber.2003.791">Sieber et al 2003</xref>].</p>
        <p><bold>Hamartomatous polyp syndromes.</bold> Several conditions associated with an increased risk for hamartomatous polyps and colon cancer can usually be distinguished by their extracolonic manifestations as well as hamartomatous rather than adenomatous pathology:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="jps" document-type="chapter">Juvenile polyposis syndrome</related-object> (JPS), caused by pathogenic variants in <italic toggle="yes">SMADA4</italic> and <italic toggle="yes">BMPR1A</italic></p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="pjs" document-type="chapter">Peutz-Jeghers syndrome</related-object> (PJS), caused by pathogenic variants in <italic toggle="yes">STK11</italic></p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> hamartomatous syndromes</related-object> (including Cowden syndrome and Bannayan-Riley-Ruvalcaba [BRR] syndrome), caused by pathogenic variants in <italic toggle="yes">PTEN</italic></p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="hgc" document-type="chapter"><bold>Hereditary diffuse gastric cancer</bold></related-object>
<bold>(HDGC).</bold> The gastric cancers, caused by pathogenic variant of <italic toggle="yes">CDH1</italic>, are typically adenocarcinomas.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="brca1" document-type="chapter"><bold><italic toggle="yes">BRCA1/BRCA2</italic> hereditary breast/ovarian syndrome</bold></related-object> should be considered when evaluating an individual with a family history of cancer that includes ovarian cancer.</p>
      </sec>
      <sec id="hnpcc.Management">
        <title>Management</title>
        <sec id="hnpcc.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Lynch syndrome, the evaluations summarized in <xref ref-type="sec" rid="hnpcc.Surveillance">Surveillance</xref> are recommended.</p>
        </sec>
        <sec id="hnpcc.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Management of colon cancer in a person with Lynch syndrome.</bold> If colon cancer is detected, full colectomy with ileorectal anastomosis is recommended rather than a segmental/partial colonic resection because of the high risk for metachronous cancers [<xref ref-type="bibr" rid="hnpcc.REF.lynch.1988.372">Lynch et al 1988</xref>, <xref ref-type="bibr" rid="hnpcc.REF.aarnio.1995.430">Aarnio et al 1995</xref>, <xref ref-type="bibr" rid="hnpcc.REF.church.2003.1001">Church &#x00026; Simmang 2003</xref>]. A study of 296 individuals (253 with partial resection, 43 with colectomy anastomosis) from families meeting Amsterdam Criteria found that with a median follow up of 104 months, 22% of affected individuals treated with a partial resection developed a high-risk adenoma and 25% developed a second primary colon cancer, while only 11% and 8% of affected individuals developed adenomas and colon cancers respectively [<xref ref-type="bibr" rid="hnpcc.REF.kalady.2010.507">Kalady et al 2010</xref>]. Note: Because the diagnosis of Lynch syndrome is often not considered until after treatment of an initial cancer, many individuals diagnosed with Lynch syndrome have previously had their cancer treated with a limited colonic resection.</p>
          <p>Although timing may be difficult, evaluating the tumor biopsy specimen by MSI and IHC (and, if indicated, the <italic toggle="yes">MHL1</italic> promoter methylation status) may help determine the optimal surgical approach. A study suggests that persons with colon cancer are open to being approached about genetic testing at the time of their diagnosis [<xref ref-type="bibr" rid="hnpcc.REF.porteous.2003.1400">Porteous et al 2003</xref>].</p>
          <p>The other tumors seen in Lynch syndrome are managed as in the general population.</p>
        </sec>
        <sec id="hnpcc.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>Prophylactic removal of the uterus and ovaries (prior to the development of cancer) can be considered after childbearing is completed.</p>
          <p>Because routine colonoscopy is an effective preventive measure for colon cancer, prophylactic colectomy (removal of the colon prior to the development of cancer) is generally not recommended for individuals with Lynch syndrome.</p>
        </sec>
        <sec id="hnpcc.Surveillance">
          <title>Surveillance</title>
          <p><bold>Colon cancer.</bold> Regular colonoscopy with removal of precancerous polyps reduces the incidence of colon cancer in individuals with Lynch syndrome. A 2009 study of a Finish cohort with high compliance with screening found no increase in mortality for individuals with Lynch syndrome over their mutation-negative relatives, indicating that annual colonoscopy could help with the prevention and detection of colon cancer [<xref ref-type="bibr" rid="hnpcc.REF.j_rvinen.2009.4793">J&#x000e4;rvinen et al 2009</xref>]. In this study four individuals were diagnosed with colon cancer and lymph node metastases: one was diagnosed during baseline colonoscopy; the other three were diagnosed more than two years after their last colonoscopy. Therefore, the current recommendation is colonoscopy every one to two years beginning between ages 20 and 25 years or two to five years before the earliest diagnosis in the family, whichever is earlier [<xref ref-type="bibr" rid="hnpcc.REF.j_rvinen.2009.4793">J&#x000e4;rvinen et al 2009</xref>, <xref ref-type="bibr" rid="hnpcc.REF.engel.2010.174">Engel et al 2010</xref>, <xref ref-type="bibr" rid="hnpcc.REF9">NCCN 2013</xref>].</p>
          <p>In <italic toggle="yes">MSH6</italic> and <italic toggle="yes">PMS2</italic> heterozygotes the risk for colon cancer is lower; thus colonoscopy screening may be delayed until age 30 years [<xref ref-type="bibr" rid="hnpcc.REF.senter.2008.419">Senter et al 2008</xref>, <xref ref-type="bibr" rid="hnpcc.REF.baglietto.2010.193">Baglietto et al 2010</xref>].</p>
          <p>Note: Colonoscopy is recommended rather than flexible sigmoidoscopy because of the predominance of proximal colon cancers in Lynch syndrome [<xref ref-type="bibr" rid="hnpcc.REF.lynch.1996.1149">Lynch &#x00026; Smyrk 1996</xref>].</p>
          <p><bold>Endometrial cancer.</bold> Endometrial cancer surveillance is less well established than that for colon cancer.</p>
          <p>Because many endometrial cancers can be diagnosed at early stages on the basis of symptoms, women should be educated about the signs of endometrial cancers.</p>
          <p>Currently the National Comprehensive Cancer Network (NCCN) does not recommend any specific screening for endometrial or ovarian cancer [<xref ref-type="bibr" rid="hnpcc.REF9">NCCN 2013</xref>].</p>
          <p>Studies on the effectiveness of transvaginal ultrasound examination and endometrial biopsy have had conflicting results. Further studies are needed to determine if the combination of transvaginal ultrasound examination and endometrial biopsy detect endometrial cancers at an early age.</p>
          <list list-type="bullet">
            <list-item>
              <p>In a study of the use of transvaginal ultrasound examination to screen for endometrial cancer, no cancers were detected; however, two cancers were detected on the basis of symptoms manifest during the course of the study [<xref ref-type="bibr" rid="hnpcc.REF.doveedwin.2002.1708">Dove-Edwin et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>A report from a Finnish cohort found that endometrial sampling and transvaginal ultrasound every two to three years resulted in the diagnosis of early stage cancers. However, because endometrial cancer often presents with symptoms at an early stage, it was not clear that the screening improved detection [<xref ref-type="bibr" rid="hnpcc.REF.j_rvinen.2009.4793">J&#x000e4;rvinen et al 2009</xref>].</p>
            </list-item>
          </list>
          <p><bold>Ovarian cancer</bold>. No specific ovarian cancer screening trials have been conducted in women with Lynch syndrome. Of note, screening for ovarian cancer using CA-125 blood tests and transvaginal ultrasound examination has not been effective in other high-risk populations such as women with a <italic toggle="yes">BRCA1</italic> or <italic toggle="yes">BRCA2</italic> pathogenic variant [<xref ref-type="bibr" rid="hnpcc.REF.evans.2009.593">Evans et al 2009</xref>].</p>
          <p><bold>Gastric and duodenal cancers.</bold> Upper endoscopy surveillance can be used to screen for cancers of the stomach and duodenum. Currently the NCCN recommends beginning upper endoscopy with a side-viewing scope and extended duodenoscopy between ages 30 and 35 years and repeating them every three to five years depending on the findings. Those with evidence of chronic inflammation, atrophic gastropathy, and/or intestinal metaplasia would be candidates for more frequent evaluation. Note: Biopsies should be evaluated for <italic toggle="yes">H pylori</italic> infections so that appropriate treatment can be given as needed [<xref ref-type="bibr" rid="hnpcc.REF9">NCCN 2013</xref>].</p>
          <p>Data regarding the effectiveness of upper endoscopy examination for the early detection of gastric cancer in Lynch syndrome are limited.</p>
          <list list-type="bullet">
            <list-item>
              <p>One study suggested no benefit from this screening for gastric cancer because of the lack of identifiable precursor lesions [<xref ref-type="bibr" rid="hnpcc.REF.renkonensinisalo.2002.574">Renkonen-Sinisalo et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>A study looking at gastric cancer risk in a Dutch study suggested that the level of risk is sufficient to warrant screening; however, since 87% of the cancers occurred after age 45 years, it may be most cost effective to initiate screening at age 45 years [<xref ref-type="bibr" rid="hnpcc.REF.capelle.2010.487">Capelle et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="hnpcc.REF.schulmann.2005.590">Schulmann et al [2005]</xref> found that approximately 50% of the small bowel cancers in a cohort with Lynch syndrome were located in the duodenum, suggesting that upper endoscopy may be useful for screening. However, no trials to determine the efficacy of upper endoscopy for screening for duodenal cancers have been conducted.</p>
            </list-item>
          </list>
          <p><bold>Distal small bowel.</bold> At this time data are limited regarding screening for cancer development in the distal small bowel. Capsule endoscopy and small bowel enterography are available for evaluating the small bowel, but at this time there is no recommendation for routine use of these approaches for small bowel screening, although they may be helpful for evaluating symptomatic individuals.</p>
          <p><bold>Urinary tract.</bold> NCCN recommends consideration of annual urine analysis beginning between age 25 and 30 years [<xref ref-type="bibr" rid="hnpcc.REF9">NCCN 2013</xref>].</p>
          <p><bold>Other cancers.</bold> At this time, no specific screening recommendations for other Lynch syndrome associated cancers exist. Affected individuals should be encouraged to follow other general population screening guidelines and to seek prompt medical attention for changes in health or persistent symptoms.</p>
        </sec>
        <sec id="hnpcc.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Cigarette smoking increases the risk for colorectal cancer in Lynch syndrome [<xref ref-type="bibr" rid="hnpcc.REF.watson.2004.2429">Watson et al 2004</xref>, <xref ref-type="bibr" rid="hnpcc.REF.pande.2010.1331">Pande et al 2010</xref>].</p>
        </sec>
        <sec id="hnpcc.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Early recognition of cancers associated with Lynch syndrome may allow for timely intervention and improved final outcome; thus, surveillance of asymptomatic at-risk relatives for early manifestations is appropriate.</p>
          <p>When an MMR pathogenic variant has been identified in a family with Lynch syndrome, molecular genetic testing for the pathogenic variant should be offered to all first-degree relatives (parents, sibs, and children).</p>
          <list list-type="bullet">
            <list-item>
              <p>The sibs should be considered at risk even if the parents have not had cancer because most Lynch syndrome results from an inherited (not <italic toggle="yes">de novo</italic>) pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If clinical history and family history cannot identify the parent from whom the proband inherited the MMR gene pathogenic variant, molecular genetic testing for the pathogenic variant should be offered to both parents to determine which has the MMR gene pathogenic variant.</p>
            </list-item>
          </list>
          <p>In general, molecular genetic testing for Lynch syndrome is not recommended for at-risk individuals younger than age 18 years. However, because cancer has been diagnosed in individuals with Lynch syndrome at very young ages [<xref ref-type="bibr" rid="hnpcc.REF.huang.2001.629">Huang et al 2001</xref>], it is recommended that screening begin ten years before the earliest age of onset in the family. In such instances, it is appropriate to offer molecular genetic testing to children younger than age 18 years prior to initiating cancer screening.</p>
          <p>See <xref ref-type="sec" rid="hnpcc.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="hnpcc.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Ideally cancer screening exams would be planned around a pregnancy. An affected woman would be encouraged to be current on her cancer screening before attempting to become pregnant. If an affected woman is diagnosed with cancer during pregnancy, she should be counseled about cancer treatment options and their potential implications for the fetus.</p>
        </sec>
        <sec id="hnpcc.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><bold>Chromoendoscopy and intensive colonoscopy.</bold> A 2008 study compared the effectiveness of chromoendoscopy and intensive colonoscopy inspection in early detection of polyps in persons with Lynch syndrome. Following standard colonoscopy, study participants were randomized to receive a second colonoscopy with chromoendoscopy or a second colonoscopy with careful inspection. This study found that although polyps are frequently missed during standard colonoscopy, no difference was observed between the number of additional polyps detected by chromoendoscopy and by the careful second-look colonoscopy [<xref ref-type="bibr" rid="hnpcc.REF.stoffel.2008.470">Stoffel et al 2008</xref>]. Further studies are needed to determine if novel colonoscopy techniques confer additional benefit for the screening of persons with Lynch syndrome.</p>
          <p>
            <bold>Chemoprevention research studies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A four-arm trial comparing placebo versus aspirin and placebo versus resistant starch was conducted among 1071 individuals with Lynch syndrome. No effect on the risk for colorectal neoplasia was seen in either the aspirin or resistant starch intervention group [<xref ref-type="bibr" rid="hnpcc.REF.burn.2008.2567">Burn et al 2008</xref>]. However, when this cohort was followed for ten years, the group receiving aspirin did show a 63% reduction in colon cancer incidence [<xref ref-type="bibr" rid="hnpcc.REF.burt.2012.507">Burt 2012</xref>]. Resistant starch was not found to have an impact on colon cancer risk [<xref ref-type="bibr" rid="hnpcc.REF.mathers.2012.1242">Mathers et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Whereas oral contraceptives reduce the risk for endometrial and ovarian cancer in women who are at general population risk, it is unknown if they confer the same benefit in women with Lynch syndrome.</p>
            </list-item>
          </list>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="hnpcc.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="hnpcc.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Lynch syndrome is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="hnpcc.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The majority of individuals diagnosed with Lynch syndrome have inherited the pathogenic variant from a parent. However, because of incomplete penetrance, variable age of cancer development, cancer risk reduction resulting from screening or prophylactic surgery, or early death, not all individuals with mutation of a Lynch syndrome-causing MMR gene have a parent who had cancer.</p>
            </list-item>
            <list-item>
              <p>If clinical and family history cannot identify the parent from whom the proband inherited the MMR pathogenic variant, molecular genetic testing should be offered to both parents to determine which one has the pathogenic variant identified in the proband.</p>
            </list-item>
            <list-item>
              <p>The precise new mutation rate for Lynch syndrome is unknown but estimated to be extremely low [<xref ref-type="bibr" rid="hnpcc.REF.bisgaard.2003.56">Bisgaard &#x00026; Bernstein 2003</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Sibs of a proband are at a 50% risk of inheriting the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing for the pathogenic variant identified in the family should be offered to all sibs.</p>
            </list-item>
            <list-item>
              <p>The sibs should still be considered at risk even if the parents have not had cancer because most Lynch syndrome results from an inherited, not a <italic toggle="yes">de novo</italic>, pathogenic variant.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with Lynch syndrome has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on their relationship to the proband. Family history or molecular genetic testing can help determine whether maternal or paternal relatives are at risk. Offspring of family members found to have pathogenic variants or diagnosed with Lynch syndrome-related cancers can be assumed to be at 50% risk. For branches of the family in which the at-risk person died without developing a cancer, Bayesian analysis can be used to help calculate the risk to the offspring.</p>
        </sec>
        <sec id="hnpcc.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="hnpcc.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Specific risk issues.</bold> Several factors can hinder the diagnosis of Lynch syndrome based on family history. Screening and removal of precancerous polyps and prophylactic surgery may prevent colon or endometrial cancer in some at-risk relatives; some who died young from other causes may never have developed cancer.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with Lynch syndrome has the pathogenic variant or clinical evidence of Lynch syndrome, it is possible that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, <italic toggle="yes">de novo</italic> mutation in an MMR gene is thought to be rare and other possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored [<xref ref-type="bibr" rid="hnpcc.REF.bisgaard.2003.56">Bisgaard &#x00026; Bernstein 2003</xref>].</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>Genetic cancer risk assessment and counseling.</bold> For a comprehensive description of the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without molecular genetic testing, see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cancer.gov/about-cancer/causes-prevention/genetics/risk-assessment-pdq">Cancer Genetics Risk Assessment and Counseling &#x02013; for health professionals</ext-link> (part of PDQ<sup>&#x000ae;</sup>, National Cancer Institute).</p>
          <p><bold>Testing of at-risk asymptomatic adults</bold> for Lynch syndrome is possible using the techniques described in <xref ref-type="sec" rid="hnpcc.Molecular_Genetic_Testing">Molecular Genetic Testing</xref>. Such testing is not useful in predicting whether symptoms will occur, or if they do, what the age of onset, severity and type of symptoms, or rate of disease progression will be. When testing at-risk individuals for Lynch syndrome, an affected family member should be tested first to confirm the molecular diagnosis in the family.</p>
          <p>Genetic counseling is recommended prior to making decisions about genetic testing. <xref ref-type="bibr" rid="hnpcc.REF.brain.2005.255">Brain et al [2005]</xref> suggest that a single educational session may be adequate for genetic counseling for asymptomatic adults who are at risk for treatable conditions. However, preparatory information may be helpful in encouraging individuals to reflect on issues not previously considered. Genetic counseling includes discussion of the clinical and psychosocial implications of genetic testing for the individual and for family members. Studies assessing psychological adjustment following genetic testing have not found that learning that one has a Lynch syndrome pathogenic variant is associated with adverse psychological outcomes or clinically significant increases in distress. However, subgroups of individuals with Lynch syndrome, such as those with high levels of pre-test distress, poor quality of life, or low levels of social support, are at greater risk of experiencing psychological morbidity [<xref ref-type="bibr" rid="hnpcc.REF.vernon.1997.73">Vernon et al 1997</xref>, <xref ref-type="bibr" rid="hnpcc.REF.dudok_dewit.1998.745">Dudok deWit et al 1998</xref>, <xref ref-type="bibr" rid="hnpcc.REF.gritz.1999.35">Gritz et al 1999</xref>].</p>
          <p><bold>Molecular genetic testing of asymptomatic individuals younger than age 18 years.</bold> In general, genetic testing for Lynch syndrome is not recommended for at-risk individuals younger than age 18 years. Guidelines established jointly by the American College of Medical Genetics and the American Society of Human Genetics state that predictive genetic testing should be performed in individuals younger than age 18 years only if it will affect their medical management. It is recommended that the decision to test be postponed until an individual reaches adulthood and can make an independent decision because management for cancer risk associated with Lynch syndrome is not recommended to begin until age 20 years. Since there are rare reported cases of individuals with Lynch syndrome diagnosed with cancer at very young ages [<xref ref-type="bibr" rid="hnpcc.REF.huang.2001.629">Huang et al 2001</xref>], it is recommended that screening begin ten years before the earliest age of onset in the family. In some families, individuals may need to begin screening before age 18 years. See also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="hnpcc.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the pathogenic variant in the family has been identified, prenatal diagnosis for pregnancies at increased risk may be available through laboratories offering testing for the gene/disease of interest or custom testing.</p>
          <p>Requests for prenatal testing for typically adult-onset conditions which (like Lynch syndrome) have treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="hnpcc.Resources">
        <title>Resources</title>
      </sec>
      <sec id="hnpcc.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="hnpcc.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Lynch syndrome is caused by pathogenic variants in genes involved with the mismatch repair (MMR) pathway. This pathway functions to identify and remove single nucleotide mismatches or insertions and deletion loops. Pathogenic variants in four of the MMR genes can cause Lynch syndrome [<xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2003.1174">Peltom&#x000e4;ki 2003</xref>]. The functions of the mismatch repair genes can be disrupted by missense variants, truncating variants, splice site variants, large deletions, or genomic rearrangements. In addition, germline deletion within <italic toggle="yes">EPCAM</italic>, which is not an MMR gene, can disrupt the MMR pathway by inactivating the adjacent MMR gene <italic toggle="yes">MSH2</italic>, even though <italic toggle="yes">MSH2</italic> itself has not been mutated.</p>
          <p>Genetic modifiers of cancer risk in Lynch syndrome have been reported:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="bibr" rid="hnpcc.REF.zecevic.2006.139">Zecevic et al [2006]</xref> found that shorter <italic toggle="yes">IGF1</italic>-CA repeats are associated with an increased risk (HR=2.36; 95% CI=1.28 to 4.36) for colon cancer and earlier age of onset (44 vs. 56.5 years) among individuals who have a pathogenic variant in an MMR gene.</p>
            </list-item>
            <list-item>
              <p>A variant of <italic toggle="yes">RNASEL</italic> has also been reported to be associated with an earlier age of onset, with an average age of onset of 40 years for individuals homozygous for the Arg462 variant and 34 years for individuals homozygous for the Gly462 variant [<xref ref-type="bibr" rid="hnpcc.REF.kr_ger.2005.566">Kr&#x000fc;ger et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="hnpcc.REF.pande.2008.2393">Pande et al [2008]</xref> evaluated a number of genes including <italic toggle="yes">CYP1A1, EPHX1, GSTT1, GSTM1,</italic> and <italic toggle="yes">GSTP1</italic> and found that two sequence variants in <italic toggle="yes">CYP1A1</italic> may contribute to earlier age of colon cancer onset in individuals with Lynch syndrome.</p>
            </list-item>
            <list-item>
              <p>Analysis of several single nucleotide polymorphisms reported to be associated with colorectal cancer risk were not found to modify the cancer risk in individuals with MMR pathogenic variants [<xref ref-type="bibr" rid="hnpcc.REF.win.2013.1578">Win et al 2013</xref>].</p>
            </list-item>
          </list>
          <sec id="hnpcc.MLH1">
            <title>
              <italic toggle="yes">MLH1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MLH1</italic> is 57,357 kb in length, with 19 coding exons encoding a protein of 756 amino acids. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hnpcc" object-id="hnpcc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 200 different pathogenic variants have been reported in <italic toggle="yes">MLH1</italic> [<xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2003.1174">Peltom&#x000e4;ki 2003</xref>, <xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2004.269">Peltom&#x000e4;ki &#x00026; Vasen 2004</xref>]; see <related-object source-id="gene" document-id="hnpcc" object-id="hnpcc.molgen.TA">Table A</related-object>. Deletions account for 5%-10% of germline <italic toggle="yes">MLH1</italic> pathogenic variants.</p>
            <p>Constitutional inactivation of <italic toggle="yes">MLH1</italic> by methylation, along with somatic loss of heterozygosity of the functional allele, has been reported as a rare cause of Lynch syndrome (~0.6%) [<xref ref-type="bibr" rid="hnpcc.REF.niessen.2009.737">Niessen et al 2009</xref>]. These individuals have silencing of one <italic toggle="yes">MLH1</italic> allele, throughout their tissues, due to methylation of the promoter and a Lynch syndrome phenotype. Most of such cases are simplex (i.e., a single occurrence in a family), but a few cases of inherited hypermethylation have been reported [<xref ref-type="bibr" rid="hnpcc.REF.goel.2011.869">Goel et al 2011</xref>]. These cases are not detectable by either sequence analysis or duplication/deletion analysis of <italic toggle="yes">MLH1</italic>.</p>
            <p><bold>Normal gene product.</bold> DNA mismatch repair protein Mlh1 dimerizes with the product of the <italic toggle="yes">PMS2</italic> gene (PMS1 protein homolog 2) to coordinate the binding of other proteins involved with mismatch repair including the helicases, the protein encoded by <italic toggle="yes">EXO1</italic>, proliferating cell nuclear antigen (PCNA), single-stranded-DNA binding-protein (RPA), and DNA polymerases [<xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2003.1174">Peltom&#x000e4;ki 2003</xref>].</p>
            <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">MLH1</italic> acts in a recessive manner at the cellular level where there is an absence of functional Mlh1 protein in the tumor cells. This results from inactivation of both <italic toggle="yes">MLH1</italic> alleles in the tumor, which often occurs as a result of an inactivating mutation or silencing of the <italic toggle="yes">MLH1</italic> promoter by hypermethylation.</p>
          </sec>
          <sec id="hnpcc.MSH2">
            <title>
              <italic toggle="yes">MSH2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MSH2</italic> comprises 16 exons encoding a protein of 934 amino acids. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hnpcc" object-id="hnpcc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 170 pathogenic variants have been identified in <italic toggle="yes">MSH2</italic> [<xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2003.1174">Peltom&#x000e4;ki 2003</xref>, <xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2004.269">Peltom&#x000e4;ki &#x00026; Vasen 2004</xref>]. The higher proportion of Alu repeats may contribute to the higher rate of genomic rearrangements in <italic toggle="yes">MSH2</italic> than in <italic toggle="yes">MLH1</italic> [<xref ref-type="bibr" rid="hnpcc.REF.van_der_klift.2005.123">van der Klift et al 2005</xref>]. At least 20% of germline <italic toggle="yes">MSH2</italic> pathogenic variants are exon or multiexon deletions.</p>
            <p><bold>Normal gene product.</bold> DNA mismatch repair protein MSH2, the protein encoded by <italic toggle="yes">MSH2</italic>, forms a heterodimer with either DNA mismatch repair protein MSH6 or MSH3 and functions to identify mismatches. A sliding clamp model has been suggested to describe the structure of the heterodimer. Mismatches in the DNA are thought to be detected as the clamp slides along the DNA [<xref ref-type="bibr" rid="hnpcc.REF.fishel.1993.1027">Fishel et al 1993</xref>, <xref ref-type="bibr" rid="hnpcc.REF.gruber.2003.137">Gruber &#x00026; Kohlmann 2003</xref>].</p>
            <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">MSH2</italic> acts in a recessive manner at the cellular level where there is an absence of functional Msh2 protein in the tumor cells. This results from inactivation of both <italic toggle="yes">MSH2</italic> alleles in the tumor, which often occurs by the mechanism of loss of heterozygosity (LOH). <italic toggle="yes">MSH2</italic> promoter methylation has been shown to be the inactivating event that silences the normal allele in individuals with an M<italic toggle="yes">SH2</italic> inactivating pathogenic variant. Of note, this is not a common cause of sporadic colon cancer.</p>
          </sec>
          <sec id="hnpcc.MSH6">
            <title>
              <italic toggle="yes">MSH6</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MSH6</italic> comprises ten exons encoding a protein of 1360 amino acids. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hnpcc" object-id="hnpcc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 30 pathogenic variants have been identified in <italic toggle="yes">MSH6</italic> [<xref ref-type="bibr" rid="hnpcc.REF.peltom_ki.2004.269">Peltom&#x000e4;ki &#x00026; Vasen 2004</xref>]. Exon or multiexon deletions are a rare cause of germline <italic toggle="yes">MSH6</italic> pathogenic variants.</p>
            <p><bold>Normal gene product.</bold> The protein encoded by <italic toggle="yes">MSH6</italic>, DNA mismatch repair protein MSH6, forms a heterodimer with DNA mismatch repair protein MSH2 and functions to identify mismatches by a sliding clamp model [<xref ref-type="bibr" rid="hnpcc.REF.fishel.1993.1027">Fishel et al 1993</xref>, <xref ref-type="bibr" rid="hnpcc.REF.gruber.2003.137">Gruber &#x00026; Kohlmann 2003</xref>].</p>
            <p><bold>Abnormal gene product.</bold> MSH6 acts in a recessive manner at the cellular level where there is an absence of functional MSH6 protein in the tumor cells. This results from inactivation of both <italic toggle="yes">MSH6</italic> alleles in the tumor, which often occurs by the mechanism of loss of heterozygosity (LOH).</p>
          </sec>
          <sec id="hnpcc.PMS2">
            <title>
              <italic toggle="yes">PMS2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">PMS2</italic> comprises 15 exons encoding a protein of 862 amino acids. Multiple pseudogenes have been identified at 7p22, 7p12-13, 7q11, and 7q22 [<xref ref-type="bibr" rid="hnpcc.REF.nicolaides.1995.195">Nicolaides et al 1995</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hnpcc" object-id="hnpcc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Germline pathogenic variants in <italic toggle="yes">PMS2</italic> are rare [<xref ref-type="bibr" rid="hnpcc.REF.hendriks.2006.312">Hendriks et al 2006</xref>]. Single nucleotide variants and large gene rearrangements have been reported. Studies that have included large deletion testing have found that up to 20% of pathogenic variants may be large deletions (<xref ref-type="table" rid="hnpcc.T.summary_of_germline_molecular_ge">Table 3</xref>). Large deletion testing of <italic toggle="yes">PMS2</italic> is technically difficult due to numerous pseudogenes and it presents significant challenges to laboratories trying to provide comprehensive large deletion testing for the whole gene. The currently available MLPA (multiplex ligation-dependent probe amplification) kit can detect deletions but does not clarify whether the deletion may be in one of the pseudogenes. Testing in coordination with a panel of reference samples can help determine whether deletions are clinically significant [<xref ref-type="bibr" rid="hnpcc.REF.vaughn.2011.1063">Vaughn et al 2011</xref>].</p>
            <p><bold>Normal gene product.</bold> See <xref ref-type="sec" rid="hnpcc.MLH1"><italic toggle="yes">MLH1</italic></xref>, <bold>Normal gene product</bold>.</p>
            <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">PMS2</italic> acts in a recessive manner at the cellular level where there is an absence of functional <italic toggle="yes">PMS2</italic> protein in the tumor cells. This results from inactivation of both <italic toggle="yes">PMS2</italic> alleles in the tumor, which often occurs by the mechanism of loss of heterozygosity (LOH).</p>
          </sec>
          <sec id="hnpcc.EPCAM">
            <title>
              <italic toggle="yes">EPCAM</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">EPCAM</italic> comprises nine exons encoding a protein of 314 amino acids. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hnpcc" object-id="hnpcc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Deletions involving the transcription termination signal of <italic toggle="yes">EPCAM</italic> are causative in 1% to 2.8% of families with Lynch syndrome. Other <italic toggle="yes">EPCAM</italic> pathogenic variants that do not affect the transcription termination signal cause autosomal recessive congenital tufting enteropathy [<xref ref-type="bibr" rid="hnpcc.REF.sivagnanam.2010.222">Sivagnanam et al 2010</xref>].</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">EPCAM</italic> expression varies in tissues. High levels of expression were found in colorectal stem cells while low levels of expression were detected in leukocytes [<xref ref-type="bibr" rid="hnpcc.REF.ligtenberg.2009.112">Ligtenberg et al 2009</xref>]. Little is known about <italic toggle="yes">EPCAM</italic> expression in most other tissues predisposed to Lynch syndrome-related cancers.</p>
            <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">EPCAM</italic> deletions are thought to arise from Alu-mediated recombination events [<xref ref-type="bibr" rid="hnpcc.REF.kuiper.2011.407">Kuiper et al 2011</xref>]. Elimination of the <italic toggle="yes">EPCAM</italic> transcription termination signal results in transcription continuing into <italic toggle="yes">MSH2</italic> and silencing of the <italic toggle="yes">MSH2</italic> promoter by methylation. Through this mechanism the <italic toggle="yes">MSH2</italic> allele in <italic toggle="yes">cis</italic> configuration with the <italic toggle="yes">EPCAM</italic> deletion becomes inactivated in the tissues in which <italic toggle="yes">EPCAM</italic> is expressed, while the other <italic toggle="yes">MSH2</italic> allele is unaffected. These pathogenic variants are transmitted in an autosomal dominant manner, as are germline variants in genes involved in MMR [<xref ref-type="bibr" rid="hnpcc.REF.ligtenberg.2009.112">Ligtenberg et al 2009</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="hnpcc.References">
        <title>References</title>
        <sec id="hnpcc.Published_GuidelinesConsensus_Stat">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="hnpcc.Published_GuidelinesConsensus_Stat.reflist0">
            <ref id="hnpcc.REF1">
              <mixed-citation publication-type="webpage">American College of Medical Genetics technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/gim/journal/v16/n1/full/gim2013166a.html">online</ext-link>. 2014. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF2">
              <mixed-citation publication-type="webpage">American College of Medical Genetics/American Society of Human Genetics. Joint statement on genetic testing for colon cancer (pdf). Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.acmg.net/StaticContent/StaticPages/Colon_Cancer.pdf">online</ext-link>. 2000. Accessed 10-4-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF3">
              <mixed-citation publication-type="webpage">American Gastroenterological Association. Medical position statement: hereditary colorectal cancer and genetic testing (pdf). Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.med.upenn.edu/gastro/documents/AGApositionstatementhereditarycoloncancertesting.pdf">online</ext-link>. 2001. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF4">
              <mixed-citation publication-type="webpage">American Society of Clinical Oncology. Expert statement: collection and use of a cancer family history for oncology providers. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/content/32/8/833.long">online</ext-link>. 2014. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF5">
              <mixed-citation publication-type="webpage">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/content/28/5/893.long">online</ext-link>. 2010. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF6">
              <mixed-citation publication-type="webpage">American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (FAP and HNPCC). Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.fascrs.org/sites/default/files/downloads/publication/identification_and_testing_of_a_patient_at_risk_for_dominantly_inherited_colorectal_cancer_supporting_documentation_1.pdf">online</ext-link>. 2003. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF7">
              <mixed-citation publication-type="webpage">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF.giardiello.2001">
              <mixed-citation publication-type="webpage">Giardiello FM, Brensinger JD, Petersen GM. American Gastroenterological Association technical review on hereditary colorectal cancer and genetic testing (pdf). Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.med.upenn.edu/gastro/documents/AGAtechnicalreviewhereditarycolorectalcancertesting.pdf">online</ext-link>. 2001. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF9">
              <mixed-citation publication-type="webpage">National Comprehensive Cancer Network. Guidelines for colorectal cancer screening. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/f_guidelines.asp">online</ext-link>. Login required. 2013.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF10">
              <mixed-citation publication-type="webpage">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF11">
              <mixed-citation publication-type="webpage">National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://link.springer.com/article/10.1007%2Fs10897-011-9465-7/fulltext.html">online</ext-link>. 2011. Accessed 10-5-15.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="hnpcc.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="hnpcc.Literature_Cited.reflist0">
            <ref id="hnpcc.REF.aarnio.1995.430">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aarnio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nystrom-Lahti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome.</article-title>
                <source>Int J Cancer</source>
                <volume>64</volume>
                <fpage>430</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">8550246</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.aarnio.1997.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aarnio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salovaara</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome.</article-title>
                <source>Int J Cancer</source>
                <volume>74</volume>
                <fpage>551</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9355980</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.aarnio.1999.214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aarnio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sankila</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pukkala</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salovaara</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltomaki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Cancer risk in mutation carriers of DNA-mismatch-repair genes.</article-title>
                <source>Int J Cancer</source>
                <volume>81</volume>
                <fpage>214</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10188721</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.abdelrahman.2005.1542">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abdel-Rahman</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ollikainen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariola</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nystrom-Lahti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knuutila</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltomaki</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations.</article-title>
                <source>Oncogene</source>
                <volume>24</volume>
                <fpage>1542</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15674332</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF16">
              <mixed-citation publication-type="webpage">American Cancer Society. Surveillance and health services research. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cancer.org/research/acsresearchers/about-surveillance-and-health-services-research">online</ext-link>. 2002. Accessed 10-5-15.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF.backes.2009.486">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Backes</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leon</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ivanov</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suarez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankel</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Malley</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.</article-title>
                <source>Gynecol Oncol.</source>
                <volume>114</volume>
                <fpage>486</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">19515405</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.baglietto.2010.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baglietto</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowty</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez Garcia</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vriends</surname>
                    <given-names>AH</given-names>
                  </name>
                  <collab>Dutch Lynch Syndrome Study Group</collab>
                </person-group>
                <article-title>Cartwright NR, Barnetson RA, Farrington SM, Tenesa A, Hampel H, Buchanan D, Arnold S, Young J, Walsh MD, Jass J, Macrae F, Antill Y, Winship IM, Giles GG, Goldblatt J, Parry S, Suthers G, Leggett B, Butz M, Aronson M, Poynter JN, Baron JA, Le Marchand L, Haile R, Gallinger S, Hopper JL, Potter J, de la Chapelle A, Vasen HF, Dunlop MG, Thibodeau SN, Jenkins MA. Risks of Lynch syndrome cancers for MSH6 mutation carriers.</article-title>
                <source>J Natl Cancer Inst.</source>
                <year>2010</year>
                <volume>102</volume>
                <fpage>193</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">20028993</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.bakry.2014.987">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bakry</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aronson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimawi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farah</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alharbi</surname>
                    <given-names>QK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alharbi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shamvil</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Shachar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mistry</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Constantini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dvir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qaddoumi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollett</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelies</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malkin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouffet</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawkins</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabori</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <article-title>Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.</article-title>
                <source>Eur J Cancer.</source>
                <year>2014</year>
                <volume>50</volume>
                <fpage>987</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">24440087</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.bapat.2009.967">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bapat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegmund</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jass</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotterchio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grove</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahnen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newcomb</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marchand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seminara</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Colon Cancer Family Registry. The association of tumor microsatellite instability phenotype with family history of colorectal cancer.</article-title>
                <source>Cancer Epidemiol Biomarkers Prev.</source>
                <year>2009</year>
                <volume>18</volume>
                <fpage>967</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">19258475</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.barnetson.2006.2751">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barnetson</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenesa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrington</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholl</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetnarskyj</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porteous</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunlop</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <article-title>Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.</article-title>
                <source>N Engl J Med.</source>
                <year>2006</year>
                <volume>354</volume>
                <fpage>2751</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16807412</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.barrow.2009.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barrow</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alduaij</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shenton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clancy</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalloo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.</article-title>
                <source>Clin Genet</source>
                <volume>75</volume>
                <fpage>141</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19215248</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.beamer.2012.1058">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beamer</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espenschied</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazer</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weitzel</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <article-title>Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.</article-title>
                <source>J Clin Oncol.</source>
                <year>2012</year>
                <volume>30</volume>
                <fpage>1058</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">22355048</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.bellizzi.2009.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellizzi</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankel</surname>
                    <given-names>WL</given-names>
                  </name>
                </person-group>
                <article-title>Colorectal cancer due to deficiency in DNA mismatch repair function: a review.</article-title>
                <source>Adv Anat Pathol.</source>
                <year>2009</year>
                <volume>16</volume>
                <fpage>405</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">19851131</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.berends.2002.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berends</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mensink</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Sluis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hordijk-Hos</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hollema</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karrenbeld</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Zee</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleibeuker</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.</article-title>
                <source>Am J Hum Genet</source>
                <volume>70</volume>
                <fpage>26</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">11709755</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.bisgaard.2003.56">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bisgaard</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>HNPCC mutation rate (published abstract).</article-title>
                <source>Familial Cancer</source>
                <volume>2</volume>
                <fpage>56</fpage>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.boland.1998.5248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidransky</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eshleman</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burt</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meltzer</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez-Bigas</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodde</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranzani</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivastava</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.</article-title>
                <source>Cancer Res.</source>
                <volume>58</volume>
                <fpage>5248</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">9823339</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.bouzourene.2010.167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouzourene</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Losi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhattar</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.</article-title>
                <source>Fam Cancer</source>
                <volume>9</volume>
                <fpage>167</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">19949877</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.brain.2005.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sivell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennert</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>France</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampson</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>An exploratory comparison of genetic counselling protocols for HNPCC predictive testing.</article-title>
                <source>Clin Genet</source>
                <volume>68</volume>
                <fpage>255</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">16098015</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.burn.2008.2567">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macrae</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;slein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olschwang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisgaard</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramesar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertario</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindblom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Side</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunlop</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jass</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodde</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathers</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>CAPP2 Investigators. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.</article-title>
                <source>N Engl J Med.</source>
                <year>2008</year>
                <volume>359</volume>
                <fpage>2567</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">19073976</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.burt.2012.507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burt</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>Diagnosing Lynch syndrome: more light at the end of the tunnel.</article-title>
                <source>Cancer Prev Res (Phila)</source>
                <year>2012</year>
                <volume>5</volume>
                <fpage>507</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">22491516</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.capelle.2010.487">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Capelle</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Grieken</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lingsma</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steyerberg</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klokman</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuipers</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <article-title>Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.</article-title>
                <source>Gastroenterology.</source>
                <year>2010</year>
                <volume>138</volume>
                <fpage>487</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">19900449</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.chadwick.2001.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chadwick</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyatt</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niemann</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meek</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma.</article-title>
                <source>J Med Genet</source>
                <volume>38</volume>
                <fpage>461</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11474654</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.charbonnier.2000.2760">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Charbonnier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raux</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouot</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Limacher</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saurin</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puisieux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olschwang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments.</article-title>
                <source>Cancer Res</source>
                <volume>60</volume>
                <fpage>2760</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">10850409</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.chen.2006.1479">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nafa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romans</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Euhus</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzler</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jass</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parmigiani</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Colon Cancer Family Registry. Prediction of germline mutations and cancer risk in the Lynch syndrome.</article-title>
                <source>JAMA</source>
                <year>2006</year>
                <volume>296</volume>
                <fpage>1479</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">17003396</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.church.2003.1001">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmang</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer).</article-title>
                <source>Dis Colon Rectum</source>
                <volume>46</volume>
                <fpage>1001</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">12907889</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.cunningham.2001.780">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tester</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parc</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgart</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halling</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonnell</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaid</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh Vockley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubly</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michels</surname>
                    <given-names>VV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>780</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">11524701</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.de_leeuw.2000.328">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Leeuw</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dierssen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenter</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brocker-Vriends</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stormorken</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menko</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornelisse</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morreau</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.</article-title>
                <source>J Pathol</source>
                <volume>192</volume>
                <fpage>328</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">11054716</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.den_bakker.2003.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>den Bakker</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seynaeve</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kliffen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinjens</surname>
                    <given-names>WN</given-names>
                  </name>
                </person-group>
                <article-title>Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis colorectal cancer.</article-title>
                <source>Histopathology.</source>
                <year>2003</year>
                <volume>43</volume>
                <fpage>297</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12940783</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.dinh.2011.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dinh</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosner</surname>
                    <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atwood</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burt</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.</article-title>
                <source>Cancer Prev Res (Phila)</source>
                <year>2011</year>
                <volume>4</volume>
                <fpage>9</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">21088223</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.doveedwin.2002.1708">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dove-Edwin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boks</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goff</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenter</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma.</article-title>
                <source>Cancer</source>
                <volume>94</volume>
                <fpage>1708</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">11920532</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.dudok_dewit.1998.745">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dudok deWit</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tibben</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duivenvoorden</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niermeijer</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passchier</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.</article-title>
                <source>J Med Genet.</source>
                <year>1998</year>
                <month>Sep</month>
                <volume>35</volume>
                <issue>9</issue>
                <fpage>745</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">9733033</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.duraturo.2011.1643">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Duraturo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liccardo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Rosa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grosso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izzo</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Association of low-risk MSH2 and MSH2 variant alleles with Lynch syndrome: probability of synergistic effects.</article-title>
                <source>Int J Cancer.</source>
                <year>2011</year>
                <volume>129</volume>
                <fpage>1643</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">21128252</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.durno.2010.2449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Durno</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherman</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations.</article-title>
                <source>Am J Gastroenterol.</source>
                <year>2010</year>
                <volume>105</volume>
                <fpage>2449</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">20531397</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.egapp.2009.35">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>EGAPP</collab>
                </person-group>
                <article-title>Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group1. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.</article-title>
                <source>Genet Med.</source>
                <year>2009</year>
                <volume>11</volume>
                <fpage>35</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">19125126</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.engel.2010.174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahner</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goecke</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schackert</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloor</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinke</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelsang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;slein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f6;rgens</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dechant</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Knebel Doeberitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000fc;schoff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedrichs</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;ttner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeffler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmiegel</surname>
                    <given-names>W</given-names>
                  </name>
                  <collab>German HNPCC Consortium</collab>
                </person-group>
                <article-title>Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.</article-title>
                <source>Clin Gastroenterol Hepatol.</source>
                <year>2010</year>
                <volume>8</volume>
                <fpage>174</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">19835992</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.entius.2000.1784">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Entius</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drillenburg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuypers</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offerhaus</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome.</article-title>
                <source>Clin Cancer Res</source>
                <volume>6</volume>
                <fpage>1784</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10815898</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.evans.2009.593">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaarenstroom</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stirling</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shenton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maehle</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000f8;rum</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalloo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apold</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porteous</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Asperen</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.</article-title>
                <source>J Med Genet.</source>
                <year>2009</year>
                <volume>46</volume>
                <fpage>593</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18413372</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.fishel.1993.1027">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fishel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lescoe</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodner</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.</article-title>
                <source>Cell</source>
                <volume>75</volume>
                <fpage>1027</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">8252616</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.gargiulo.2009.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gargiulo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torrini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ollila</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nasti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastorino</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cusano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battistuzzi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mastracci</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarino</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciallero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgonovo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nystr&#x000f6;m</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi-Scarr&#x000e0;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mareni</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghiorzo</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.</article-title>
                <source>Fam Cancer.</source>
                <year>2009</year>
                <volume>8</volume>
                <fpage>547</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">19728162</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.goel.2011.869">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leung</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagasaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhees</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hotchkiss</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banerji</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Packham</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hitchins</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <article-title>De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.</article-title>
                <source>Int J Cancer.</source>
                <year>2011</year>
                <volume>128</volume>
                <fpage>869</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">20473912</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.gritz.1999.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gritz</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vernon</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baile</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marani</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frazier</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <article-title>Distress in the cancer patient and its association with genetic testing and counseling for hereditary non-polyposis colon cancer.</article-title>
                <source>Cancer Res Ther Ctrl.</source>
                <year>1999</year>
                <volume>8</volume>
                <fpage>35</fpage>
                <lpage>49</lpage>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.gruber.2003.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlmann</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The genetics of hereditary non-polyposis colorectal cancer.</article-title>
                <source>J Natl Compr Canc Netw.</source>
                <volume>1</volume>
                <fpage>137</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">19764157</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.guilford.1999.249">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guilford</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grady</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markowitz</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajput</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiesner</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgart</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Limacher</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Findlay</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeve</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.</article-title>
                <source>Hum Mutat</source>
                <volume>14</volume>
                <fpage>249</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">10477433</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.hamilton.1995.839">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadopoulos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krush</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berk</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tetu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burger</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taqi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booker</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offerhaus</surname>
                    <given-names>GJA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tersmette</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzler</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>The molecular basis of Turcot's syndrome.</article-title>
                <source>N Engl J Med</source>
                <volume>332</volume>
                <fpage>839</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">7661930</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.hampel.2006.7810">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panescu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lockman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sotamaa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fix</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comeras</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Jeunesse</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clendenning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penzone</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombardi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunn</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eaton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewandowski</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaccarello</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.</article-title>
                <source>Cancer Res.</source>
                <year>2006</year>
                <volume>66</volume>
                <fpage>7810</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16885385</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.hampel.2005.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephens</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pukkala</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sankila</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.</article-title>
                <source>Gastroenterology</source>
                <volume>129</volume>
                <fpage>415</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">16083698</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.haraldsdottir.2014.553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haraldsdottir</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bekaii-Saab</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Prostate cancer incidence in males with Lynch syndrome.</article-title>
                <source>Genet Med.</source>
                <year>2014</year>
                <volume>16</volume>
                <fpage>553</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24434690</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.heald.2013.1336">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heald</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plesec</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pai</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patil</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moline</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharp</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalady</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.</article-title>
                <source>J Clin Oncol.</source>
                <year>2013</year>
                <volume>31</volume>
                <fpage>1336</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">23401454</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.hegde.2014.101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hegde</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferber</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samowitz</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganguly</surname>
                    <given-names>A</given-names>
                  </name>
                  <collab>Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee</collab>
                </person-group>
                <article-title>ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis).</article-title>
                <source>Genet Med.</source>
                <year>2014</year>
                <volume>16</volume>
                <fpage>101</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">24310308</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.hendriks.2006.312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hendriks</surname>
                    <given-names>YM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jagmohan-Changur</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Klift</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morreau</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Puijenbroek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tops</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Os</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausems</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breuning</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brocker-Vriends</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).</article-title>
                <source>Gastroenterology</source>
                <volume>130</volume>
                <fpage>312</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">16472587</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.huang.2001.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavine</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pham</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carethers</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Germline characterization of early-aged onset of hereditary non- polyposis colorectal cancer.</article-title>
                <source>J Pediatr</source>
                <volume>138</volume>
                <fpage>629</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">11343035</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.iino.2000.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simms</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winship</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furlong</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leggett</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jass</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer.</article-title>
                <source>Gut</source>
                <volume>47</volume>
                <fpage>37</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">10861262</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.j_rvinen.2009.4793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>J&#x000e4;rvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renkonen-Sinisalo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akt&#x000e1;n-Coll&#x000e1;n</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltom&#x000e4;ki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation negative family members.</article-title>
                <source>J Clin Oncol.</source>
                <year>2009</year>
                <volume>27</volume>
                <fpage>4793</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19720893</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.jo.2005.1022">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jo</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandipalliam</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shannon</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niendorf</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan-Smutko</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hur</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Correlation of polyp number and family history of colon cancer with germline MYH mutations.</article-title>
                <source>Clin Gastroenterol Hepatol</source>
                <volume>3</volume>
                <fpage>1022</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16234049</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.kalady.2010.507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kalady</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGannon</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manilich</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazio</surname>
                    <given-names>VW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria.</article-title>
                <source>Ann Surg.</source>
                <year>2010</year>
                <volume>252</volume>
                <fpage>507</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">20739851</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.kastrinos.2009.1790">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kastrinos</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukherjee</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tayob</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparr</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandipalliam</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoffel</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Risk of pancreatic cancer in families with Lynch syndrome.</article-title>
                <source>JAMA</source>
                <year>2009</year>
                <volume>302</volume>
                <fpage>1790</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19861671</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.kastrinos.2011.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kastrinos</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steyerberg</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercado</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balmana</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegnund</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burbidge</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenstrup</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>The PREMM(1,2,6) Model predicts risk of MLH1, MSH2, and MSH6 germline mutations.</article-title>
                <source>Gastroenterology.</source>
                <year>2011</year>
                <volume>140</volume>
                <fpage>73</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">20727894</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.kawaguchi.2009.1541">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kawaguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanokura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuwabara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirasawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susumu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer.</article-title>
                <source>Int J Oncol.</source>
                <year>2009</year>
                <volume>34</volume>
                <fpage>1541</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19424571</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.kempers.2011.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kempers</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuiper</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ockeloen</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chappuis</surname>
                    <given-names>PO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahner</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schackert</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinke</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloor</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;ttner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verwiel</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Krieken</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagtegaal</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Post</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niessen</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogervorst</surname>
                    <given-names>FB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leter</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gille</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aalfs</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redeker</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hes</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tops</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nesselrooij</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Gijn</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez Garc&#x000ed;a</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bunyan</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoffel</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Culver</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palomares</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velsher</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papp</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ol&#x000e1;h</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leung</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kessel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiemeney</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogerbrugge</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligtenberg</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.</article-title>
                <source>Lancet Oncol.</source>
                <year>2011</year>
                <volume>12</volume>
                <fpage>49</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">21145788</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.kowalski.1997.219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kowalski</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutch</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzog</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rader</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodfellow</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers.</article-title>
                <source>Genes Chromosomes Cancer</source>
                <volume>18</volume>
                <fpage>219</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">9071575</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.kr_ger.2005.566">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kr&#x000fc;ger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silber</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorgens</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangold</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagenstecher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Knebel Doeberitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeslein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietmaier</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stemmler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruschoff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schackert</surname>
                    <given-names>HK</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.</article-title>
                <source>Lancet Oncol</source>
                <volume>6</volume>
                <fpage>566</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">16054567</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.kuiper.2011.407">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuiper</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissers</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkatachalam</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodmer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoenselaar</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haufe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamping</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niessen</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogervorst</surname>
                    <given-names>FB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gille</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redeker</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tops</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Gijn</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Ouweland</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahner</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinke</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahl</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloor</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stemmler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bunyan</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Culver</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagtegaal</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Krieken</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schackert</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogerbrugge</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kessel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligtenberg</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Recurrence and variability of germline EPCAM deletions in Lynch syndrome.</article-title>
                <source>Hum Mutat.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>407</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">21309036</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.laken.1997.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laken</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oddoux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostrer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markowitz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klimstra</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhanwar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winawer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offit</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luce</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzler</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.</article-title>
                <source>Nat Genet</source>
                <volume>17</volume>
                <fpage>79</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">9288102</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.ligtenberg.2009.112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ligtenberg</surname>
                    <given-names>MJL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuiper</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebeda</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voorendt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>TY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodmer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoenselaar</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendriks-Cornelissen</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsui</surname>
                    <given-names>WY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kessel</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuen</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Krieken</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leung</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogerbrugge</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3&#x02019; exons of TACSTD1.</article-title>
                <source>Nat Genet.</source>
                <year>2009</year>
                <volume>41</volume>
                <fpage>112</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19098912</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.lindor.2005.1979">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bapat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aronson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jass</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeMarchand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grove</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newcomb</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terdiman</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conrad</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moslein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ziogas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anton-Culver</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Andrade</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegmund</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boardman</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seminara</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.</article-title>
                <source>JAMA</source>
                <volume>293</volume>
                <fpage>1979</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">15855431</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.lu.2005.569">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlmann</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandipalliam</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conrad</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terdiman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershenson</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broaddus</surname>
                    <given-names>RR</given-names>
                  </name>
                </person-group>
                <article-title>Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.</article-title>
                <source>Obstet Gynecol.</source>
                <year>2005</year>
                <volume>105</volume>
                <fpage>569</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">15738026</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.lu.1998.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawabata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomizu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyazono</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuasa</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>HNPCC associated with germline mutation in the TGF-beta type II receptor gene.</article-title>
                <source>Nat Genet</source>
                <volume>19</volume>
                <fpage>17</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9590282</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.lynch.1996.1149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smyrk</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review.</article-title>
                <source>Cancer</source>
                <volume>78</volume>
                <fpage>1149</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">8826936</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.lynch.1993.1535">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smyrk</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanspa</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavalieri</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>CR</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review.</article-title>
                <source>Gastroenterology</source>
                <volume>104</volume>
                <fpage>1535</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">8482467</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.lynch.1988.372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kriegler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanspa</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smyrk</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzgibbons</surname>
                    <given-names>RJ</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Cristofaro</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II).</article-title>
                <source>Dis Colon Rectum</source>
                <volume>31</volume>
                <fpage>372</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">3366037</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.machin.2002.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Machin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catasus</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conde-Zurita</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balmana</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnadas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matias-Guiu</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.</article-title>
                <source>J Cutan Pathol</source>
                <volume>29</volume>
                <fpage>415</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">12139636</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.mathers.2012.1242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mathers</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Movahedi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macrae</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeslein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olschwang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertario</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisgaard</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunlop</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindblom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murday</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramesar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Side</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerdes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pylvanainen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodde</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burn</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>CAPP2 Investigators. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.</article-title>
                <source>Lancet Oncol.</source>
                <year>2012</year>
                <volume>13</volume>
                <fpage>1242</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23140761</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.maxwell.2001.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risinger</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berchuck</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Favorable survival associated with microsatellite instability in endometrioid endometrial cancers.</article-title>
                <source>Obstet Gynecol</source>
                <volume>97</volume>
                <fpage>417</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11239648</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.misago.2000.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Misago</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narisawa</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Sebaceous neoplasms in Muir-Torre syndrome.</article-title>
                <source>Am J Dermatopathol</source>
                <volume>22</volume>
                <fpage>155</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">10770437</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.miyaki.1997.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miyaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konishi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikuchi-Yanoshita</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muraoka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igari</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer.</article-title>
                <source>Nat Genet</source>
                <volume>17</volume>
                <fpage>271</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">9354786</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.moline.2013.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moline</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahdi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biscotti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roma</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heald</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rose</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michener</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.</article-title>
                <source>Gynecol Oncol.</source>
                <year>2013</year>
                <volume>130</volume>
                <fpage>121</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23612316</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.muellerkoch.2005.1733">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mueller-Koch</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelsang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopp</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohse</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aust</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muders</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daum</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiemann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabowski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerker</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer.</article-title>
                <source>Gut</source>
                <volume>54</volume>
                <fpage>1733</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15955785</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.nagasaka.2010.3098">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nagasaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhees</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloor</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gebert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naomoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goel</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers.</article-title>
                <source>Cancer Res.</source>
                <year>2010</year>
                <volume>70</volume>
                <fpage>3098</fpage>
                <lpage>108</lpage>
                <pub-id pub-id-type="pmid">20388775</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF90">
              <mixed-citation publication-type="webpage">NCCN. National Comprehensive Cancer Network Guidelines for colorectal cancer screening. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#colorectal_screening">online</ext-link>. Registration required. 2013.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF.nicolaides.1995.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicolaides</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shell</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadopoulos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzler</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <article-title>Genomic organization of the human PMS2 gene family.</article-title>
                <source>Genomics.</source>
                <year>1995</year>
                <volume>30</volume>
                <fpage>195</fpage>
                <lpage>206</lpage>
                <pub-id pub-id-type="pmid">8586419</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.niessen.2009.737">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niessen</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westers</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligtenberg</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kooi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jager</surname>
                    <given-names>PO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Groote</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dijkhuizen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olderode-Berends</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hollema</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleibeuker</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.</article-title>
                <source>Genes Chromosomes Cancer.</source>
                <year>2009</year>
                <volume>48</volume>
                <fpage>737</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">19455606</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.nilbert.2009.209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nilbert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Therkildsen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nissen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akerman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum.</article-title>
                <source>Fam Cancer.</source>
                <year>2009</year>
                <volume>8</volume>
                <fpage>209</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">19130300</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.obermair.2010.2678">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Obermair</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Youlden</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newcomb</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.</article-title>
                <source>Int J Cancer.</source>
                <year>2010</year>
                <volume>127</volume>
                <fpage>2678</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">20533284</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.ou.2009.340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westers</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jager</surname>
                    <given-names>PO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kooi</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niessen</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eggen</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nielsen</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleibeuker</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome.</article-title>
                <source>Genes Chromosomes Cancer.</source>
                <year>2009</year>
                <volume>48</volume>
                <fpage>340</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">19156873</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.pande.2008.2393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pande</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osterwich</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broaddus</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frazier</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.</article-title>
                <source>Cancer Epidemiol Biomarkers Prev.</source>
                <year>2008</year>
                <volume>17</volume>
                <fpage>2393</fpage>
                <lpage>401</lpage>
                <pub-id pub-id-type="pmid">18768509</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.pande.2010.1331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pande</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeMarchand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newcomb</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frazier</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>CI</given-names>
                  </name>
                </person-group>
                <article-title>Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center.</article-title>
                <source>Clin Cancer Res.</source>
                <year>2010</year>
                <volume>16</volume>
                <fpage>1331</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20145170</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.park.2000.2994">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.</article-title>
                <source>Clin Cancer Res</source>
                <year>2000</year>
                <volume>6</volume>
                <fpage>2994</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10955776</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.peltom_ki.2003.1174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peltom&#x000e4;ki</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Role of DNA mismatch repair defects in the pathogenesis of human cancer.</article-title>
                <source>J Clin Oncol</source>
                <volume>21</volume>
                <fpage>1174</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12637487</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.peltom_ki.2004.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peltom&#x000e4;ki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database.</article-title>
                <source>Dis Markers</source>
                <volume>20</volume>
                <fpage>269</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">15528792</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.plaschke.2004.4486">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Plaschke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kr&#x000fc;ger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagenstecher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangold</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeslein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gebert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Knebel Doeberitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000fc;schoff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeffler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schackert</surname>
                    <given-names>HK</given-names>
                  </name>
                </person-group>
                <article-title>Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 and MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.</article-title>
                <source>J Clin Oncol.</source>
                <year>2004</year>
                <volume>22</volume>
                <fpage>4486</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">15483016</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.ponti.2006.2302">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ponti</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Losi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedroni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucci-Cordisco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Gregorio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellancani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidenari</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2006</year>
                <volume>126</volume>
                <fpage>2302</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16826164</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.porteous.2003.1400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Porteous</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunckley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appleton</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunlop</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cull</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study.</article-title>
                <source>Br J Cancer</source>
                <volume>89</volume>
                <fpage>1400</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">14562005</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.rabban.2014.793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rabban</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calkins</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karnezis</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grenert</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanco</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <article-title>Association of Tumor Morphology With Mismatch-repair Protein Status in Older Endometrial Cancer Patients: Implications for Universal Versus Selective Screening Strategies for Lynch Syndrome.</article-title>
                <source>Am J Surg Pathol.</source>
                <year>2014</year>
                <volume>38</volume>
                <fpage>793</fpage>
                <lpage>800</lpage>
                <pub-id pub-id-type="pmid">24503759</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.rahner.2013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rahner</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinke</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlegelberger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisinger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olschwang</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2013</year>
                <volume>21</volume>
                <issue>1</issue>
                <comment/>
                <pub-id pub-id-type="doi">10.1038/ejhg.2012.164</pub-id>
                <pub-id pub-id-type="pmid">22892529</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.raymond.2013a.3012">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Everett</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furtado</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gustafson</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammer</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoffel</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenson</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Else</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Adrenocortical carcinoma is a lynch syndrome-associated cancer.</article-title>
                <source>J Clin Oncol.</source>
                <year>2013a</year>
                <volume>31</volume>
                <fpage>3012</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23752102</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.raymond.2013b.1713">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukherjee</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoffel</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kastrinos</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooney</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <article-title>Elevated risk of prostate cancer among men with Lynch syndrome.</article-title>
                <source>J Clin Oncol.</source>
                <year>2013b</year>
                <volume>31</volume>
                <fpage>1713</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23530095</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.renkonensinisalo.2002.574">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renkonen-Sinisalo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sipponen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aarnio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julkunen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarna</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer.</article-title>
                <source>Scand J Gastroenterol</source>
                <volume>37</volume>
                <fpage>574</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12059060</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.resnick.2009.530">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Resnick</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straughn</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Backes</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <article-title>Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.</article-title>
                <source>Obstet Gynecol.</source>
                <year>2009</year>
                <volume>114</volume>
                <fpage>530</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19701031</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.rodriguezbigas.1998.240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rodriguez-Bigas</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myrhoj</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macrae</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St John</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertario</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fidalgo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madlensky</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozen</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC.</article-title>
                <source>Cancer</source>
                <volume>83</volume>
                <fpage>240</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9669805</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.ryan.2014.437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Win</surname>
                    <given-names>AK</given-names>
                  </name>
                </person-group>
                <article-title>Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis.</article-title>
                <source>Cancer Epidemiol Biomarkers Prev.</source>
                <year>2014</year>
                <volume>23</volume>
                <fpage>437</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">24425144</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.schulmann.2005.590">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schulmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brasch</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunstmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagenstecher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelsang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knaebel</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruschoff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knebel-Doeberitz</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeslein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meltzer</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schackert</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tympner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangold</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmiegel</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>HNPCC-associated small bowel cancer: clinical and molecular characteristics.</article-title>
                <source>Gastroenterology</source>
                <volume>128</volume>
                <fpage>590</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15765394</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.schwartz.1995.90">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torre</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>The Muir-Torre syndrome: a 25-year retrospect.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>33</volume>
                <fpage>90</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">7601953</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.senter.2008.419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Senter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clendenning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sotamaa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindblom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagerstedt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winship</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowty</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baglietto</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>The clinical phenotype of Lynch syndrome due to germline PMS2 mutations.</article-title>
                <source>Gastroenterology.</source>
                <year>2008</year>
                <volume>135</volume>
                <fpage>419</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">18602922</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.shia.2008.293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shia</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part 1: The utility of immunohistochemistry.</article-title>
                <source>J Mol Diagn.</source>
                <year>2008</year>
                <volume>10</volume>
                <fpage>293</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">18556767</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.sieber.2003.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sieber</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crabtree</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinimann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fidalgo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisgaard</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orntoft</surname>
                    <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>IP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Multiple colorectal adenomas, classic adenomatous polyposis, and germline mutations in MYH.</article-title>
                <source>N Engl J Med</source>
                <volume>348</volume>
                <fpage>791</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12606733</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.sijmons.2000.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hollema</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mensink</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Hout</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoekstra</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleibeuker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molenaar</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodde</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non-polyposis colorectal cancer.</article-title>
                <source>Genes Chromosomes Cancer.</source>
                <year>2000</year>
                <volume>29</volume>
                <fpage>353</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11066081</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.sivagnanam.2010.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sivagnanam</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaible</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szigeti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byrd</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finegold</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranganathan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gopalakrishna</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatevian</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kellermayer</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Further evidence for EpCAM as the gene for congenital tufting enteropathy.</article-title>
                <source>Am J Med Genet.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>222</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20034091</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.sjursen.2010.579">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sjursen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haukane</surname>
                    <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grindedal</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aarset</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stormorken</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engebretsen</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonsrud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bj&#x000f8;rnevoll</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andresen</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariansen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavik</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilde</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowitz-Lothe</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maehle</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f8;ller</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>579</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">20587412</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.south.2008.277">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>South</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comeras</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankel</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>The frequency of Muir-Torre syndrome among Lynch syndrome families.</article-title>
                <source>J Natl Cancer Inst</source>
                <year>2008</year>
                <volume>100</volume>
                <fpage>277</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">18270343</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.stoffel.2009.1621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stoffel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukherjee</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tayob</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kastrinos</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparr</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandipalliam</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <article-title>Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.</article-title>
                <source>Gastroenterology.</source>
                <year>2009</year>
                <volume>137</volume>
                <fpage>1621</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19622357</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.stoffel.2008.470">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stoffel</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turgeon</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockwell</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Normolle</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuck</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresalier</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcon</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruffin</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <collab>Great Lakes-New England Clinical Epidemiology and Validation Center of the Early Detection Research Network</collab>
                </person-group>
                <article-title>Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).</article-title>
                <source>Cancer Prev Res (Phila)</source>
                <year>2008</year>
                <volume>1</volume>
                <fpage>470</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19138994</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.suzui.1998.126">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suzui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morishita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Genetic alterations in a patient with Turcot's syndrome.</article-title>
                <source>Pathol Int</source>
                <volume>48</volume>
                <fpage>126</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">9589476</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.syngal.2000.641">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodner</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.</article-title>
                <source>J Med Genet</source>
                <volume>37</volume>
                <fpage>641</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10978352</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.thompson.2004.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meldrum</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crooks</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McPhillips</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spigelman</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations.</article-title>
                <source>Clin Genet.</source>
                <year>2004</year>
                <volume>65</volume>
                <fpage>215</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">14756672</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.tsai.1997.435">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booker</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacon</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Evidence against genetic anticipation in familial colorectal cancer.</article-title>
                <source>Genet Epidemiol</source>
                <volume>14</volume>
                <fpage>435</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">9271715</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.tutlewska.2013.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tutlewska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurzawski</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Germlie deletions in the EPCAM gene as a cause of Lynch syndrome.</article-title>
                <source>Hered Cancer Clin Pract.</source>
                <year>2013</year>
                <volume>11</volume>
                <fpage>9</fpage>
                <pub-id pub-id-type="pmid">23938213</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.umar.2004.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Umar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terdiman</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruschoff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgart</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamelin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiatt</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jass</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindblom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltomaki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsey</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez-Bigas</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawk</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freedman</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivastava</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>96</volume>
                <fpage>261</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14970275</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.van_der_klift.2005.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Klift</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verkuilen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tops</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otway</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohonen-Corish</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barana</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delozier-Blanchet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulkes</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moslein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodde</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).</article-title>
                <source>Genes Chromosomes Cancer</source>
                <volume>44</volume>
                <fpage>123</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">15942939</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.van_der_post.2010.464">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Post</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiemeny</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligtenberg</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witjes</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulsbergen-van de Kaa</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodmer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaap</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kets</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Krieken</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogerbrugge</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>464</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">20591884</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.vasen.1991.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC).</article-title>
                <source>Dis Colon Rectum</source>
                <volume>34</volume>
                <fpage>424</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">2022152</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.vasen.2001.4074">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stormorken</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menko</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagengast</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleibeuker</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffioen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taal</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <article-title>MSH2 mutation carriers are at higher risk fo cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.</article-title>
                <source>J Clin Oncol.</source>
                <year>2001</year>
                <volume>19</volume>
                <fpage>4074</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">11600610</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.vasen.1994.1675">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jass</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomizu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <article-title>The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer.</article-title>
                <source>Anticancer Res.</source>
                <year>1994</year>
                <volume>14</volume>
                <fpage>1675</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7979205</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.vasen.1999.1453">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.</article-title>
                <source>Gastroenterology</source>
                <volume>116</volume>
                <fpage>1453</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10348829</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.vaughn.2011.1063">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vaughn</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samowitz</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swensen</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Avoidance of pseudogene interfence in the detection of 3&#x02019; deletions in PMS2.</article-title>
                <source>Hum Mutat.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>1063</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">21618646</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.vernon.1997.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vernon</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gritz</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perz</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baile</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer.</article-title>
                <source>Health Psychol</source>
                <volume>16</volume>
                <fpage>73</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">9028817</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.wagner.2003.1088">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrows</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Klift</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franken</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verkuijlen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geugien</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaghmohan-Changur</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breukel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers-Heijboer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morreau</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Puijenbroek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coronel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinarski</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okimoto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodde</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>1088</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">12658575</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.wahlberg.2002.3485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wahlberg</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmeits</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syngal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodner</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.</article-title>
                <source>Cancer Res</source>
                <volume>62</volume>
                <fpage>3485</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">12067992</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.walsh.2010.2214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchanan</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummings</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clendenning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walters</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeone</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spurdle</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suthers</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelzer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gattas</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodall</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macrae</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marchand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bapat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuckin</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.</article-title>
                <source>Clin Cancer Res.</source>
                <year>2010</year>
                <volume>16</volume>
                <fpage>2214</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">20215533</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.walsh.2012.722">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchanan</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clendenning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Win</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walters</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spring</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavluk</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suthers</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jass</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahnen</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosty</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry.</article-title>
                <source>Mod Pathol.</source>
                <year>2012</year>
                <volume>25</volume>
                <fpage>722</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">22322191</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.watson.2004.2429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashwathnarayan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roy</surname>
                    <given-names>HK</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome).</article-title>
                <source>Arch Intern Med</source>
                <volume>164</volume>
                <fpage>2429</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15596632</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.watson.2001.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butzow</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madlensky</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fidalgo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.</article-title>
                <source>Gynecol Oncol</source>
                <volume>82</volume>
                <fpage>223</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11531271</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.watson.1998.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez-Bigas</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smyrk</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shashidharan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franklin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.</article-title>
                <source>Cancer</source>
                <volume>83</volume>
                <fpage>259</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">9669808</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.watson.2008.444">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aarnio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;rvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myrh&#x000f8;j</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunde</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <article-title>The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.</article-title>
                <source>Int J Cancer.</source>
                <year>2008</year>
                <volume>123</volume>
                <fpage>444</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18398828</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.watson.1994.516">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer.</article-title>
                <source>Am J Med</source>
                <volume>96</volume>
                <fpage>516</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">8017449</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.weissman.2011.5">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weissman</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellcross</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bittner</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freivogel</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haidle</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaurah</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leininger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palaniappan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steenblock</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vu</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniels</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.</article-title>
                <source>J Genet Couns.</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>5</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">20931355</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.westphalen.2005.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Westphalen</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berthod</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plasilova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinimann</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer.</article-title>
                <source>Hum Genet</source>
                <volume>116</volume>
                <fpage>461</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15772852</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.wijnen.1998.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wijnen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Klift</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menko</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tops</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers Heijboer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindhout</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodde</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>MSH2 genomic deletions are a frequent cause of HNPCC.</article-title>
                <source>Nat Genet</source>
                <volume>20</volume>
                <fpage>326</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9843200</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.wimmer.2012">
              <mixed-citation publication-type="book">Wimmer K. Relationship between NF1 and constitutive mismatch repair deficiency. In Upadhyaya M, Cooper DN, eds. <italic toggle="yes">Neurofibromatosis Type 1</italic>. Berlin, Germany: Springer-Verlag; 2012:235-51.</mixed-citation>
            </ref>
            <ref id="hnpcc.REF.wimmer.2008.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wimmer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Etzler</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?</article-title>
                <source>Hum Genet.</source>
                <year>2008</year>
                <volume>124</volume>
                <fpage>105</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">18709565</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.win.2013.1578">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Win</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchanan</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenesa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowty</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giles</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winship</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boussioutas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duggan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newcomb</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marchand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?</article-title>
                <source>Eur J Cancer.</source>
                <year>2013</year>
                <volume>49</volume>
                <fpage>1578</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">23434150</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.win.2012.958">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Win</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahnen</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchanan</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clendenning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giles</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winship</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macrae</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Southey</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunawardena</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bapat</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marchand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newcomb</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.</article-title>
                <source>J Clin Oncol.</source>
                <year>2012</year>
                <volume>30</volume>
                <fpage>958</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">22331944</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.wu.1999.1291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berends</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mensink</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kempinga</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Der Zee</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hollema</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleibeuker</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buys</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>1291</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10521294</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.zecevic.2006.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zecevic</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez-Bigas</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frazier</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>98</volume>
                <fpage>139</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">16418517</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.zhang.2008.301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II: The utility of microsatellite instability testing.</article-title>
                <source>J Mol Diagn.</source>
                <year>2008</year>
                <volume>10</volume>
                <fpage>301</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18556776</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="hnpcc.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="hnpcc.Suggested_Reading.reflist0">
            <ref id="hnpcc.REF.hampel.2007.9603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panescu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lockman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sotamaa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fix</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comeras</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaJeunesse</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clendenning</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penzone</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eaton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombardi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunn</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewandowski</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaccarello</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Comment on: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.</article-title>
                <source>Cancer Res.</source>
                <year>2007</year>
                <volume>67</volume>
                <fpage>9603</fpage>
                <pub-id pub-id-type="pmid">17909073</pub-id>
              </element-citation>
            </ref>
            <ref id="hnpcc.REF.rumilla.2011.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rumilla</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schowalter</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindo</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mensink</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newcomb</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopper</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Long</surname>
                    <given-names>TI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weisenberger</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haile</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laird</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marchand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibodeau</surname>
                    <given-names>SN</given-names>
                  </name>
                </person-group>
                <article-title>Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases.</article-title>
                <source>J Mol Diagn.</source>
                <year>2011</year>
                <volume>13</volume>
                <fpage>93</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21227399</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="hnpcc.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="hnpcc.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>22 May 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 September 2012 (cd) Revision: Multi-gene panels for Lynch syndrome (hereditary non-polyposis colon cancer) available clinically</p>
            </list-item>
            <list-item>
              <p>11 August 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 November 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 February 2004 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>18 April 2003 (sg) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="hnpcc.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Microsatellite instability testing is used to identify tumors caused by defective mismatch repair by comparing the number of nucleotide repeats in a panel of microsatellite markers in normal tissue with the number from tumor tissue from the same individual. Microsatellite stability (MSS) is present if the same number of repeats is present in each marker in both the tumor and the normal tissue. Microsatellite instability (MSI) is present if the number of repeats in the tumor and the normal tissue differs. Adapted from <xref ref-type="bibr" rid="hnpcc.REF.gruber.2003.137">Gruber &#x00026; Kohlmann [2003]</xref></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hnpcc-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
